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THE SPINDLE ASSEMBLY CHECKPOINT 
 
María Maldonado, Ph.D. 
The Rockefeller University 2013 
  
Accurate chromosome segregation during cell division is essential for the maintenance 
of a cell’s genomic stability. The molecular surveillance mechanism called the spindle 
assembly checkpoint (SAC) inhibits chromosome segregation before all chromosomes 
are correctly attached (bi-oriented) on the microtubule spindle to prevent segregation 
errors that may lead to chromosomal instability and cell death. In this thesis, I have 
developed and used tools to examine the roles of different checkpoint proteins in the 
mechanism of SAC signaling. In the first part of the thesis, I manipulate the localization 
of the checkpoint protein Mad1 and show that its constitutive presence at the 
kinetochore is sufficient to induce checkpoint arrest. Being able to uncouple checkpoint 
signaling from chromosome biorientation, I use the system as a tool to examine the 
roles of checkpoint kinases in SAC signaling downstream of kinetochore recruitment of 
Mad1. I show that the kinases Mps1 and Aurora B are necessary for the maintenance of 
checkpoint arrest, independently of their other “upstream” checkpoint functions. I also 
show that localization of Mad1 at other chromosomal locations is not per se sufficient to 
induce checkpoint arrest. In the second part of the thesis, I collaborate in the 
development of a tool for the study of the protein dynein, a microtubule-associated 
motor with mitotic regulatory roles in spindle assembly, kinetochore-microtubule 
 
 
interactions and SAC silencing, as well as a variety of cargo-translocation roles in 
interphase. I examine the effects of the small molecule “ciliobrevin” in mitotic cells and 
help validate it as the first specific dynein inhibitor. Although I determine that its effects 
on the microtubule spindle will preclude its use in checkpoint silencing studies, 
ciliobrevin will still be a powerful tool for other biochemical, structural and cellular 






“Le rêve de toute cellule: devenir deux cellules.” 
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Chapter 1: Introduction to the 
Spindle Assembly Checkpoint 
Overview of the cell cycle and mitosis 
Mitosis, the biological process by which a cell divides into two “daughter” cells, is 
essential for the maintenance of organisms’ lives. In multicellular organisms, mitosis is 
necessary for growth, development, organ homeostasis and wound-healing. The 
maintenance of genetic fidelity in (most) somatic cells is essential for the well-being of 
the organism, given that genetic instability can give rise to a variety of diseases and 
death (Pfau and Amon, 2012; Holland and Cleveland, 2012).  
Before being able to divide, cells must pass through an orderly, unidirectional and 
irreversible series of phases of the cell cycle. Progression through the cell cycle is driven 
by complex, interlocking molecular circuits, powered by the activity of conserved cyclin-
dependent kinases (CDKs; Morgan, 2008a, b). The first phase of a newly formed cell is 
G1 (gap) phase, in which the cell can grow and carry out its functions. Most somatic cells 
exist in this phase or a similar, quiescent phase called G0 (for cells that do not divide). 
For a cell to be able to divide into two genetically identical daughter cells, i.e. to 
undergo mitosis, it must first duplicate its genetic material (DNA, wrapped around 
nucleosomes to form chromosomes). Upon certain proliferative stimuli, cells progress 
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from G1 to S (DNA synthesis) phase, in which chromosomes and (other cellular 
structures such as the centrosomes) are replicated. At this point, the replicated 
chromosome is held together (i.e., its two sister chromatids are under cohesion). 
Further growth and housekeeping processes are carried out during the ensuing phase, 
G2, before the cell is ready to start mitosis (M phase). During the prophase stage of 
mitosis, the chromosomes condense, the nuclear envelope breaks down and the 
microtubule cytoskeleton is rearranged into a bipolar structure called the spindle. 
Chromosomes are then bound by microtubule polymer bundles (kinetochore fibers) at a 
specialized proteinaceous structure called the kinetochore and are then aligned in the 
middle of the cell at the metaphase plate. When kinetochores of both sister chromatids 
of all kinetochores are bioriented, i.e. when each sister kinetochore of the pair is 
attached to microtubules emanating from a different spindle pole, the cell breaks the 
cohesion between the chromosomes to allow metaphase to progress into anaphase 
(Fig. 1.1). During anaphase, the separated chromatids are physically transported to 
opposite sides of the cytoplasm (driven by kinetochore fiber depolymerization), after 
which nuclear envelopes re-form (telophase) and the membrane in the middle of the 
cell ingresses into a furrow that will eventually completely separate both sides of the 
cytoplasm (cytokinesis), giving rise to two independent cells. These newly formed cells 
then enter G1 phase if they are to remain proliferative, or G0 phase if they are to 







Figure 1.1 Types of chromosome-microtubule attachment and orientation on the 
spindle. Non-bioriented chromosomes can be: (a) unattached, (b) monopolarly attached 
(only one kinetochore of the pair contacts microtubules), (c) syntelically attached (both 
kinetochores are attached by microtubules emanating from a single pole), (d) 
merotelically attached (both kinetochores are attached, but one of them contacts 
microtubules emanating from two different poles), or (e) bipolarly attached (both 
kinetochores are attached, each to microtubules emanating from a single and distinct 
pole). Biorientation only occurs when the chromosome is bipolarly attached.  
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Molecular checkpoints ensure the fidelity of cell cycle progression 
Errors in the sequence or timing of mitotic events can lead to genetic instability and cell 
death. Because of the importance of fidelity of cell division in the maintenance of 
genomic stability, cell cycle events must be tightly coordinated. Coordination of the cell 
cycle of eukaryotic cells is achieved by “checkpoints”: molecular surveillance 
mechanisms (dependent relationships) that do not allow late events to occur before the 
successful completion of early ones (Hartwell and Weinert, 1989). A number of 
checkpoints exist at different stages of the cell cycle (G1/S, S, G2/M, etc).  
For the work described here, I have focused on the spindle assembly checkpoint 
(SAC): the mechanism that arrests mitotic cells in metaphase, preventing the 
progression into anaphase until all chromosomes are bioriented and providing time for 
orientation errors to be corrected (Musacchio and Salmon, 2007). Because 
depolymerization of the kinetochore-attached microtubule fibers powers chromatid 
translocation during anaphase, proper kinetochore-microtubule interactions are 
essential to ensure faithful segregation (Mitchison et al., 1986; Gorbsky et al., 1987; 
Koshland et al., 1988). By only allowing chromosomal segregation in cells with a full 
complement of correctly attached (bioriented) chromosomes, the spindle assembly 
checkpoint prevents mis-segregation events that would lead to genetic aberrations, 





The Spindle Assembly Checkpoint  
A short history of spindle assembly checkpoint origins 
The concept of a cell cycle checkpoint was originally formally proposed by Hartwell and 
Weinert in 1989 (Hartwell and Weinert, 1989). They recognized that the order of events 
of the cell cycle is regulated in wild type cells such that late events do not occur until the 
successful completion of previous events has been finished and that these pathways of 
dependent relationships are key for the fidelity of cell division. In their seminal article, 
they review existing data and propose that a variety of such checkpoints are true 
feedback control mechanisms, as opposed to mere “substrate-product” intrinsic 
structural requirements (Hartwell and Weinert, 1989). The initial criterion for the 
identification of these pathways as control mechanisms was the existence of “relief of 
dependence conditions” such as mutations or chemical inhibition that allowed a late 
event to occur in the absence of the completion of an earlier event. Hartwell and 
Weinert argued that these relief-of-dependence observations were very unlikely to arise 
from structural changes in the proteins and thus established the concept of checkpoint 
control mechanisms. 
  In fact, Hartwell and Weinert themselves established the role of the protein 
RAD9 in the DNA damage checkpoint of budding yeast (Weinert and Hartwell, 1988). 
They showed that, at the restrictive temperature, rad9 temperature-sensitive mutants 
in which DNA damage has been induced by x-ray irradiation fail to arrest in G2 and 
instead proceed into cell division regardless of the DNA damage present (which, on the 
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contrary, causes G2 arrest in wild type cells or in rad9 mutants at the permissive 
temperatures). Furthermore, irradiated rad9 cells can efficiently repair damaged DNA if 
cells are blocked in G2 is using microtubule poisons. Thus, they established that RAD9 
forms part of a feedback mechanism (a checkpoint) that delays entry into mitosis in the 
presence of DNA damage. 
 The initial discovery of the spindle assembly checkpoint genes came a couple of 
years later from the laboratories of Andrew Hoyt and Andrew Murray (Hoyt et al., 1991; 
Li and Murray, 1991). They hypothesized that the mitotic arrest seen when microtubules 
are disrupted is also due to a checkpoint mechanism. To test this, Rong Li and Andrew 
Murray devised a screen that would differentiate “structural” mutants (e.g. with a 
deficiency in tubulin polymerization) from mutants arising from a true checkpoint 
mechanism (Li and Murray, 1991). They incubated the mutagenized budding yeast cells 
in sub-lethal concentrations of the microtubule depolymerizing agent benomyl. Under 
these conditions, three distinct responses would be seen from the different populations. 
In wild type cells, completion of mitosis would be delayed (not blocked) until a proper 
spindle could be assembled and proper biorientation, achieved. Structural mutants 
would be unable to assemble a spindle and progress through mitosis at all. On the other 
hand, mutants in the putative feedback checkpoint mechanism would fail to delay 
mitosis in response to the improperly assembled spindle and would progress through 
mitosis un-delayed, which would lead to chromosome mis-segregation and cell death. 
Moreover, this benomyl hypersensitivity should be rescued by a delay in S-phase, which 
would allow a longer time for the yeast spindle to form. From this carefully designed 
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screen, Li and Murray were able to isolate three checkpoint mutants: Mad1, Mad2 and 
Mad3 (Li and Murray, 1991). 
 Similarly, Andrew Hoyt and Tibor Roberts carried out an independent screen to 
identify relief-of-dependence mutants that would fail to arrest in mitosis with a 
disrupted spindle (Hoyt et al., 1991). They initially identified mutants that failed to 
efficiently recover from a transient, complete block of microtubule polymerization (by 
exposure to high concentrations of benomyl), presumably due to their inability to pause 
the cell cycle while the spindle recovered. Under closer inspection, a number of these 
mutants also underwent several rounds of budding in the presence of benomyl. 
Moreover, this new group of mutants was also hypersensitive to sub-lethal 
concentrations of benomyl. This screen thus identified the second group of checkpoint 
genes: Bub1, Bub2, Bub3 (Hoyt et al., 1991). 
 These two seminal screens established the existence of a feedback mechanism 
that arrests the cell cycle in mitosis in response to microtubule disruption and laid the 
foundation for the field of study of the spindle assembly checkpoint. Following the initial 
discovery of the first SAC genes, the loci were cloned and the proteins, biochemically 
and cell-biologically characterized.  
We now know that more proteins are required for or involved in checkpoint arrest 
and silencing, including the motor proteins CENP-E, CENP-F and dynein, the dynein-
interacting proteins Spindly and RZZ complex (Rod, Zwilch, ZW10), the Mad2-inhibitor 
p31/Comet, the phosphatase PP1-gamma, as well as the mitotic kinases Mps1 and 
Aurora B (Musacchio and Salmon, 2007; Musacchio, 2012).  
8 
 
Following initial discovery of checkpoint genes, researchers focused on examining 
what the primary signal for the feedback mechanism is and how the signal is transduced 
in the cytoplasm. Early studies showed that cells progress into anaphase after the last 
chromosome has been properly attached, suggesting that non-bioriented chromosomes 
produce a diffusible, “stop-anaphase” signal that prevents cell cycle progression, and 
that even a single unattached kinetochore is sufficient to induce metaphase arrest 
(Rieder et al., 1994; Rieder et al., 1995). We now understand that the presence of 
unattached or improperly attached (i.e. non-bioriented) kinetochores acts as a primary 
signal that is detected, transduced and amplified by checkpoint proteins into the 
cytoplasmic “stop-anaphase” signal. Upon biorientation of all chromosomes, the 
checkpoint is satisfied and the diffusible signal is disassembled, allowing the cell to 
progress onto chromosome segregation (Musacchio and Salmon, 2007). 
In the following sections, I shall explain how the checkpoint proteins interact with 
non-bioriented chromosomes to detect, transduce, amplify and finally silence the 
spindle assembly mechanism that inhibits APC/C-cdc20. 
Molecular basis of checkpoint arrest 
In order to progress into anaphase, the cell must degrade two key mitotic proteins: 
cyclin B and securin. Cyclin B is the binding partner and activator of cyclin-dependent 
kinase 1 (CDK1), the master regulator of mitotic entry and early mitosis. Securin is a 
protein that inhibits the protease (separase) that cleaves the cohesion between the 
sister chromatids. Once all chromosomes are bioriented, cyclin B and securin are 
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ubiquitylated by the E3 ubiquitin ligase APC/C (anaphase promoting 
complex/cyclosome) and thus targeted for degradation by the proteosome, allowing 
progression into anaphase (Barford, 2012). Accordingly, the SAC prevents anaphase 
progression until all chromosomes are bioriented by inhibiting the interaction of the 
APC/C with its co-activator cdc20. By preventing the activation of the APC/C, the SAC 
prevents the degradation of cyclin B and securin and thus keeps the cells in a state of 








Figure 1.2 Spindle assembly checkpoint (SAC) simplified circuitry. The lack of 
chromosome biorientation signals through the SAC to prevent progression into 
anaphase. The mitotic checkpoint complex (MCC, composed of C-Mad2, BubR1 and 
cdc20) inhibits cdc20 from co-activating the E3 ubiquitin ligase APC/C, preventing the 
ubiquitylation and subsequent degradation of cyclin B and securin and maintaining the 
cell in a metaphase state. Biorientation silences checkpoint signaling, allowing the 
progression into anaphase. Green font indicates anaphase-promoting activities; red 
font, anaphase-inhibiting ones.  
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Detection of the primary signal 
As mentioned above, the primary signal for spindle assembly checkpoint arrest is the 
presence of non-bioriented chromosomes, i.e. those whose kinetochores are either 
unattached by microtubules or improperly interacting with them. In fact, the 
kinetochore—the complex multi-protein structures that assemble on centromeric DNA 
at the start of mitosis and whose assembly is hierarchical and highly regulated, for 
instance by the kinases Aurora B and Mps1—is not only the site of microtubule 
attachment, but also the site of detection of the checkpoint primary signal (Cheeseman 
and Desai, 2008; Santaguida and Musacchio, 2009; DeLuca and Musacchio, 2012). 
Checkpoint protein Mad1-Mad2 tetramers are recruited to non-bioriented 
kinetochores, after which they can start the primary signal transduction and 
amplification that will lead to metaphase arrest (Hardwick and Murray, 1995; Chen et 
al., 1996; Hardwick et al., 1996; Li and Benezra, 1996; Chen et al., 1998; Waters et al., 
1998). Mad1 and Mad2 are the main detectors of the primary signal, and their 
kinetochore localization is sufficient to induce checkpoint arrest (this work, second 
Chapter). Importantly, because Mad1-Mad2 recruitment to unattached kinetochores 
occurs ‘by default’ (owing to kinetochore-localization sequences and mitotic kinase 
phosphorylation), and because this recruitment occurs early in prometaphase when 
most kinetochores are still unattached, the SAC is a constitutively active surveillance 




Transduction and amplification of the SAC primary signal. 
Given that a single kinetochore can achieve the same outcome as every unattached 
kinetochore and that the APC/C inhibitory signal must be detected throughout the 
metaphase plate to prevent an unsynchronized anaphase onset, the SAC primary signal 
must not only be transduced into a cytoplasmic signal, but also amplified. 
 In most signal transduction pathways, signal amplification is achieved by 
enzymatic catalysis. In the SAC, amplification and maintenance of the anaphase-
inhibitory signal is achieved by the combined action of checkpoint proteins such as 
Mad1 and Mad2, together with mitotic kinases such as Aurora B and Mps1. Although 
not a canonical enzyme, Mad1-bound Mad2 can indeed act as a de facto enzymatic-like 
catalyst (Lad et al., 2009; Simonetta et al., 2009). Thanks to a wealth of cellular, 
biochemical, biophysical and structural work, we now have a very detailed model (the 
“Mad2 conformational activation” or “template model”) for how Mad1 and Mad2 act at 
unattached kinetochores to transduce and amplify the primary signal of non-
biorientation into the diffusible anaphase-inhibitory signal (Luo and Yu, 2008).  
Mad1 and Mad2 can interact all throughout the cell cycle, forming a tightly bound 
tetramer consisting of a Mad1 dimer and two Mad2 molecules (Chen et al., 1999; Sironi 
et al., 2002). During interphase, the Mad1-Mad2 tetramer rests in the nucleoplasmic 
side of the nuclear membrane (Iouk et al., 2002; Lee et al., 2008). Upon nuclear 
envelope breakdown, the Mad1-Mad2 tetramer is recruited to unattached 
kinetochores, via Mad1’s kinetochore binding domain and its interactions with 
kinetochore proteins such as Ndc80, aided by phosphorylation by Mps1 (Abrieu et al., 
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2001; Martin-Lluesma et al., 2002; DeLuca et al., 2003). Cells have an excess of Mad2 
relative to Mad1, and the ratio between the two is crucial to a robust checkpoint arrest 
(Chung and Chen, 2002; Barnhart et al., 2011). 
Remarkably, Mad2 exists in two topologically distinct, stable conformational states: 
an open (O-Mad2) and a closed (C-Mad2) configuration, differing in the position of the 
N- and C-terminal strands of its beta-sheet (Luo et al., 2004). In the open-to-closed 
conversion, the N-terminal strand detaches from the beta sheet to form an extra turn 
on the first alpha-helix. More notably, the two C-terminal beta strands detach from the 
sheet, cross over and re-bind the beta sheet on the other side. This causes a loop to 
traverse the body of the beta sheet, forming a structure reminiscent of a seat belt. 
Open-Mad2 and C-Mad2 are at equilibrium with very slow inter-conversion rates; in 
HeLa cells, open Mad2 is the predominant form (Luo et al., 2004). Only C-Mad2 can bind 
cdc20 and hence ultimately lead to APC/C inhibition (Mapelli et al., 2007; Yang et al., 
2008; Luo and Yu, 2008). Therefore, C-Mad2 is the active conformer.  
Interaction of O-Mad2 with Mad1 lowers the energetic barrier of the transition 
between O-Mad2 and C-Mad2 (De Antoni et al., 2005; Yang et al., 2008). Therefore, the 
Mad1-dimer-bound Mad2 species are two C-Mad2 molecules (i.e., the core tetramer 
consists of a Mad1 dimer and two C-Mad2 protomers). These C-Mad2 molecules are 
capable of recruiting O-Mad2 molecules from the cytoplasm and promoting their 
conversion to C-Mad2 (active) molecules (Luo et al., 2004; De Antoni et al., 2005; Luo 
and Yu, 2008). These processes are entirely catalytic and reversible, i.e. the rates of 
inter-conversion are accelerated, but the equilibria are not altered. Since the Mad1-
14 
 
bound closed-Mad2 remains stably associated with the Mad1 dimer, kinetochore-
localized C-Mad2 acts as a catalyst for the conversion of a large number of cytoplasmic 
O-Mad2 (Simonetta et al., 2009). These newly formed C-Mad2 molecules can bind and 
inhibit cdc20. Although it is speculated that cdc20 binds to a high energy intermediate 
(I-Mad2) that forms during the O-to-C-Mad2 conversion (as opposed to cdc20 binding to 
a C-Mad2 that has been fully converted and released to the cytoplasm), this is still 
unclear (Luo and Yu, 2008). Another point of debate is whether C-Mad2 in the 
cytoplasm can also carry out an auto-amplification loop (converting more O-Mad2 
molecules to the closed form), to further amplify the signal (De Antoni et al., 2005). 
Although this is feasible in principle (and is supported by computational modeling 
studies; Simonetta et al., 2009), there is no biological evidence for it. On the contrary, 
recent studies in budding yeast indirectly suggest that there is no auto-amplification 
Mad2 loop in the cytoplasm (Lau and Murray, 2012). This issue remains to be more 
directly tested in yeast and in higher organisms. These uncertainties notwithstanding, it 
is clear that the primary signal of non-biorientation is detected, transduced and 
amplified by the kinetochore-bound Mad1-Mad2 core tetramer to lead to the inhibition 
of cdc20-APC/C. 
As described, this model relies entirely on Mad1 and Mad2 for the amplification of 
the stop signal; there is no mention or need for the involvement of any of the 
checkpoint kinases which are known to be essential for regulating checkpoint activity. 
This simplification partially rests on the fact that in vitro studies with purified Mad1 and 
Mad2 (and even purified chromosomes, without associated kinases) can catalyze the 
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production of the inhibitory signal by acting directly on Mad2 (Vink et al., 2006; Kulukian 
et al., 2009). Moreover, given that checkpoint kinases such as Aurora B and Mps1 have 
upstream roles in kinetochore and spindle assembly, it has been very difficult to 
determine whether these kinases also have direct roles in checkpoint signaling, 
downstream of checkpoint protein recruitment to the kinetochores (Meraldi et al., 
2004b; Lan and Cleveland; Ditchfield et al., 2003; Kallio et al., 2002; Hauf et al., 2003; 
Petersen and Hagan, 2003; Pinsky et al., 2006; Emanuele et al., 2008; Vanoosthuyse and 
Hardwick, 2009; Saurin et al. 2011). In Chapter 2, I shall describe and discuss the method 
I designed to address this difficulty. My results, together with mounting evidence from 
yeast, Xenopus and other human studies, make it now clear that Aurora B and Mps1 do 
in fact have essential roles in the maintenance of checkpoint arrest (Kallio et al., 2002; 
Petersen and Hagan, 2003; Emanuele et al., 2008; Vanoosthuyse and Hardwick, 2009; 
Maldonado and Kapoor, 2011; Santaguida et al., 2011), indicating that checkpoint 






Figure 1.3 Schematic representation of spindle assembly checkpoint establishment 
and maintenance. Mad1-C-Mad2 tetramers are recruited to unattached kinetochores. 
Mad1-bound C-Mad2 catalyses the conversion of cytoplasmic O-Mad2 to C-Mad2. C-
Mad2 binds cdc20 and, together with BubR1, forms the inhibitory MCC, which blocks 
APC/C activation and, consequently, cyclin B and securin degradation. Catalytic activity 
of checkpoint kinases such as Aurora B and Mps1 is also needed to maintain checkpoint 
signaling. The full complement of their checkpoint substrates is unknown, but it includes 
MCC components, likely, APC/C subunits and, speculatively, p31.  
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APC/C inhibition by the checkpoint 
How do checkpoint components inhibit cdc20 to prevent APC/C activation? Although C-
Mad2 can bind and inhibit cdc20 by itself in vitro, in cells C-Mad2 forms a cdc20-
inhibitory mitotic checkpoint complex (MCC; Sudakin et al., 2001; Fig. 1.3). The MCC is 
composed of cdc20 and C-Mad2, together with BubR1 and the accessory protein Bub3 
(Sudakin et al., 2001; Chao et al. 2012). Importantly, both C-Mad2 and BubR1 can bind 
and inhibit cdc20, and it has been shown in vitro and in yeast that these proteins act 
synergistically to inhibit cdc20 and prevent anaphase progression (Fang, 2002; Tang et 
al., 2001; Lau and Murray, 2012). The C-Mad2-BubR1-cdc20 trimer is indeed the most 
downstream effector of the SAC (Lau and Murray, 2012). A recent structure of this 
trimer confirmed and augmented previous biochemical studies and showed how the 
inhibition of the APC/C co-activator takes place (Chao et al., 2012). BubR1 directly 
inhibits cdc20-APC/C by using its pseudo-KEN box (one of the APC/C’s substrate 
recognition sequences) to obstruct the degron recognition patch on cdc20. C-Mad2 aids 
this interaction by optimally positioning BubR1’s pseudo-KEN box for cdc20 inhibition. 
Moreover, C-Mad2’s interactions with cdc20 (which is, effectively, trapped by C-Mad2’s 
“seat belt”) partially sequester cdc20’s APC/C interaction and activation motifs, further 
contributing to cdc20 inhibition. 
Recent studies have also shown that, although purified C-Mad2 and BubR1 can 
inhibit APC/C-cdc20 in vitro, checkpoint kinase activity is needed to sustain these 
interactions—and checkpoint arrest— in cells. For instance, Mps1-mediated 
phosphorylation of C-Mad2 have recently been found necessary for checkpoint arrest 
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maintenance, and a number of phosphorylation sites for Mps1 and other checkpoint 
kinases have been found on other MCC and APC/C-cdc20 components (Tang et al., 2004; 
King et al., 2007; Kang et al., 2008; Zich et al., 2012). This is, of course, consistent with 
the fact that Aurora B and Mps1 activities are directly needed for checkpoint signaling 
and strongly suggests that the MCC and APC/C-cdc20 may be the kinases’ cytoplasmic 
substrates whose phosphorylation prevents cell cycle progression. Identifying the full 
set of checkpoint kinase substrates is an important task for the full elucidation of the 
mechanism of checkpoint arrest. 
These remaining issues notwithstanding, the consensus is emerging that checkpoint 
signal amplification and mitotic arrest is not only mediated by Mad2’s catalytic template 
mechanism: enzyme catalysis by checkpoint kinases is also needed for the cytoplasmic 
C-Mad2 molecules to associate with BubR1 and APC/C-cdc20 in a robust manner. Given 
the importance of phosphorylation in the regulation of most other events in the cell 
cycle, and the usefulness of enzymatic activity for signal amplification, this is not too 
surprising. 
Silencing of the checkpoint signal 
Once all chromosomes have achieved bipolar attachment, the checkpoint must be 
silenced. This allows the degradation of cyclin B and securin such that chromatids can be 
segregated and anaphase, irreversibly initiated. In contrast to the numerous cell-
biological, biochemical, and structural advances in our understanding of the 
establishment of checkpoint arrest, the elucidation of checkpoint silencing pathways has 
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lagged behind. In human cells, at least three different processes for SAC silencing have 
been suggested. These include: motor-protein-based processes, such as the dynein-
dependent removal of checkpoint proteins from microtubule-attached kinetochores 
(Howell et al., 2001) and the CENP-E-mediated silencing of BubR1 signaling (Mao et al., 
2005); mechanisms that involve inhibition of active SAC signaling proteins, such as the 
p31/Comet-mediated, structural mimicry-based inhibition of “active” Mad2 (Xia et al., 
2004); pathways that mediate the chemical modification of checkpoint proteins, such as 
the ubiquitylation (and ensuing degradation) of cdc20 (Reddy et al., 2007; Nilsson et al., 
2008), or the dephosphorylation of “key” substrates of mitotic kinases by phosphatases. 
These processes contribute to SAC silencing both on the kinetochore and in the 
cytoplasm, but their relative importance and interdependence are still not well 









Figure 1.4 Schematic representation of spindle assembly checkpoint silencing 
pathways. Upon biorientation, (a) dynein removes Mad1-C-Mad2 tetramers from 
kinetochores, (b) p31 disassembles MCC and may also block O-Mad1-to-C-Mad2 
catalysis at kinetochores (c), (d) phosphatase activity (PP1-gamma and perhaps others) 
dephosphorylate checkpoint kinase substrates, both at the kinetochore and in the 
cytoplasm, all of which relieves the inhibition on APC/C, allowing cyclin B and securin 
degradation and, consequently, anaphase onset. For simplicity, other pathways such as 




At the kinetochore, the main checkpoint silencing mechanism is “dynein stripping”:  the 
motor-protein dynein mediates the removal of Mad1-Mad2 tetramers and other 
checkpoint proteins towards spindle poles. Early in mitosis, dynein is recruited to 
unattached kinetochores by the protein Spindly and the RZZ complex (Starr et al., 1998; 
Griffis et al., 2007; Inoue et al., 2008). Upon chromosome biorientation, dynein is 
activated by phospho-regulated mechanism and the “stripping” process begins. Because 
dynein depletion or reduced recruitment to kinetochores causes a delay in mitotic 
progression, it was proposed that dynein contributes to SAC silencing (Faulkner et al., 
2000; Howell et al., 2001; Stehman et al., 2007). However, it has been shown that 
detectable levels of Mad2 remain at attached kinetochores and that depletion of Mad2 
from kinetochores is not required for anaphase onset (Canman et al., 2002). Similarly, in 
Chapter 2, I show that checkpoint arrest can be overcome by kinase inhibition in the 
cytoplasm, regardless of the continued localization of Mad1-Mad2 tetramers at 
kinetochores. Hence, the extent to which, and the kinetics with which, dynein stripping 
contributes to SAC silencing are still an unresolved question. To try to examine these 
matters, I joined an ongoing collaboration with Dr James Chen’s laboratory (Stanford), 
who was in the process of validating and characterizing the first specific small molecule 
dynein inhibitor (Firestone et al., 2012). This work is discussed in Chapter 3. 
Ubiquitylation, degradation and p31/Comet 
In the cytoplasm, a variety of inter-related mechanisms have been proposed to play 
roles in checkpoint silencing. For instance, APC/C-mediated proteolysis of cyclin B, 
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securin, and Mps1 is thought to contribute to the maintenance of SAC silencing during 
anaphase, once tension is lost (Palframan et al., 2006). Similarly, auto-ubiquitylation of 
cdc20 is thought to promote its dissociation from Mad2 and the MCC to overcome the 
arrest. Interestingly, cdc20 auto-ubiquitylation-mediated turnover is also thought to be 
active throughout SAC arrest, and this is thought to allow rapid disengagement from 
MCC and checkpoint silencing once biorientation is achieved (Mansfeld et al., 2011; 
Reddy et al., 2007; Nilsson et al., 2008).  
Another protein that is thought to be involved in MCC disassembly and the release 
of cdc20 inhibition is the “C-Mad2 inhibitor” p31/Comet. This protein is structurally 
similar to C-Mad2 and can bind both Mad1- and cdc20-bound C-Mad2; however, it does 
not support further Mad2 O-to-C conversion (Yang et al., 2007). Therefore, p31/Comet 
is thought to provide a “brake” to the Mad2 template amplification at the kinetochore. 
Furthermore, by binding to cdc20-bound C-Mad2, p31/Comet not only thwarts C-
Mad2’s APC/C inhibitory activity, but also facilitates the disassembly of C-Mad2-cdc20 
complexes (in part because C-Mad2 and p31/Comet share a common binding site on 
cdc20; Yang et al., 2007). P31/Comet also promotes the autoubiquitylation and 
degradation of cdc20 during prometaphase, a homeostatic mechanism to maintain 
steady states of MCC-cdc20 that is thought to promote timely exit from mitosis, even if 
not needed for SAC silencing per se (Varetti et al., 2011). The full details of p31/Comet 
activity and its regulation, the process of cdc20 autoubiquitylation during metaphase 
and anaphase and the interactions and relative contributions between these two 




Finally, another mechanism involved in SAC silencing is the dephosphorylation of 
checkpoint effectors. Although intuitively obvious that the kinase phosphorylations 
necessary for SAC arrest must be reversed for progression into anaphase, it has only 
been recently that the process began to be clarified. Dissection of this mechanism has 
greatly benefited from studies in yeast, organisms in which, notably, most of the other 
silencing pathways are currently thought to be non-essential or non-existent. Studies in 
budding and fission yeast have shown that the phosphatase PP1-gamma is essential for 
checkpoint silencing (Pinsky et al., 2009; Vanoosthuyse and Hardwick, 2009). Further 
studies in yeast and vertebrate cells showed that PP1-gamma acts not only in the 
cytoplasm, but also at the kinetochore, and revealed that a bi-stable PP1/AuroraB 
mechanism operates to recruit PP1-gamma when kinetochores have been attached by 
microtubules (Liu et al., 2010; Meadows et al., 2011; Rosenberg et al., 2011). These 
results began to uncover how checkpoint silencing is coupled to chromosomal 
biorientation, a crucial question that remains unanswered. Determining the identity of 
all checkpoint PP1 substrates, as well as the interplay between PP1-gamma-mediated 
silencing and the other mechanisms described above will also be important questions 
for future research.  
Unresolved questions and motivation for thesis research 
Although we know a lot of the molecular details of the checkpoint mechanism, there are 
still many basic questions that have not been studied in detail. For instance: we know 
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that Mad1-Mad2’s dynamic localization (at unattached kinetochores and removed upon 
biorientation) strongly correlates with spindle checkpoint activity, but it is unknown 
whether this kinetochore localization is necessary and/or sufficient for checkpoint 
arrest. Would the sustained presence of Mad1-Mad2 at kinetochores be sufficient to 
maintain checkpoint arrest, even if all chromosomes were bioriented? If so, would 
removal of Mad1-Mad2 from kinetochores be sufficient to silence the checkpoint? Some 
evidence that suggests this removal is not necessary (Canman et al., 2002). Otherwise, 
what is the major checkpoint silencing mechanism? 
With respect to necessity of kinetochore localization of Mad1-Mad2, what are the 
roles of kinetochores in checkpoint arrest? In other words, could Mad1-Mad2 induce 
robust checkpoint arrest from ectopic locations, such as other chromosomal sites, or 
even the cytoplasm? We know that kinetochores are necessary for checkpoint signaling: 
kinetochore-null cells cannot establish the SAC and only kinetochore-bound Mad1-Mad2 
can sustain a robust O-to-C-Mad2 catalytic amplification (Janke et al., 2001; Kline et al., 
2006; Salmon and Mussachio, 2007). On the other hand, some evidence indicates that, 
if Mad1-Mad2 cannot be recruited to kinetochores (for instance, due to Bub3 depletion 
in budding yeast), checkpoint arrest can nevertheless be established from the 
cytoplasm, albeit transiently and weakly (Windecker et al., 2009). Moreover, 
overexpression overexpression of Mad2 induces metaphase arrest in a variety of 
systems, including human cells (Chen et al., 1998; Sironi et al., 2001; Howell et al., 2004; 
De Antoni et al, 2005).  This suggests that the role of kinetochores may mainly be to act 
as recruitment platforms that induce Mad1-Mad2 clustering to establish a robust 
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checkpoint arrest. Could we activate checkpoint by artificially or ectopically clustering 
Mad1-Mad2? 
If dynamic localization of Mad1-Mad2 is necessary for function, if their kinetochore 
localization is sufficient to induce checkpoint arrest and if, therefore, perturbing 
localization has downstream effects on checkpoint signaling, then we should be able to 
bypass the requirement of a primary signal for the recruitment of Mad1-Mad2 and 
ensuing checkpoint arrest by artificially tethering the proteins to kinetochores. If we 
could develop a system that, by controlling Mad1 localization, controls checkpoint 
signaling regardless of detection of the primary signal, then this uncoupling of 
checkpoint activity from chromosome biorientation would enable us to study details of 
checkpoint signaling and silencing that are not possible to study with other methods. 
For instance, we could examine the roles of “checkpoint” kinases in checkpoint 
signaling. Because kinases such as Aurora B and Mps1 have a variety of functions in 
processes that are necessary to be in place for checkpoint signaling to occur (e.g. 
assembling the spindle and kinetochores, recruiting checkpoint proteins, controlling 
kinetochore-microtubule interactions), it has been very difficult to dissect whether 
these kinases also had bona fide roles in checkpoint establishment and maintenance, or 
if the checkpoint-abrogating effects seen upon their inhibition was merely due to the 
disruption of their necessary “upstream” functions. 
In this thesis work, I have tackled some of these questions. In Chapter 2, I present an 
approach that, by constitutively localizing Mad1 at kinetochores via a fusion to the 
kinetochore protein Mis12, allows us to uncouple checkpoint signaling from 
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chromosome biorientation. I used this system to examine the roles of different 
checkpoint kinases in the maintenance of the arrest downstream of Mad1-Mad2 
kinetochore recruitment. I also used similar approaches of fusing Mad1 to non-
kinetochore chromosomal proteins to examine whether checkpoint arrest can be 
established ectopically. In Chapter 3, I describe my characterization of the mitotic 
effects of the small molecule ciliobrevin D, the first specific inhibitor of the motor 
protein dynein. This work, which was part of a collaboration with James Chen’s 
laboratory (Stanford University), sought to establish this small molecule as a tool for the 
study of checkpoint silencing. In Chapter 4, I conclude with a discussion of possible 
future directions of my findings, as well as of the spindle assembly checkpoint field in 
general. I have also included an appendix with preliminary results for follow-up studies 




Chapter 2: Constitutive Mad1 
targeting to kinetochores 
uncouples checkpoint signaling 
from chromosome biorientation 
Summary 
Accurate chromosome segregation depends on biorientation, whereby sister chromatids 
attach to microtubules emanating from opposite spindle poles. The spindle assembly 
checkpoint is a conserved surveillance mechanism in eukaryotes that inhibits anaphase 
onset until all chromosomes are bioriented (Hartwell and Weinert, 1989; Rieder et al., 
1994; Musacchio and Salmon, 2007). In current models, the recruitment of Mad2, via 
Mad1, to improperly attached kinetochores is a key step needed to stop cell cycle 
progression (Musacchio and Salmon, 2007; Chen et al., 1996; Li and Benezra, 1996; 
Chen et al., 1998). However, it is not known if the localization of Mad1-Mad2 to 
kinetochores is sufficient to block anaphase. Furthermore, it is unclear if other signaling 
proteins (e.g. Aurora B kinase; Meraldi et al., 2004b) that regulate chromosome 
biorientation have checkpoint functions downstream of Mad1-Mad2 recruitment to 
kinetochores or if they act upstream to merely quench the primary error signal (Pinsky 
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and Biggins, 2005; Pinsky et al., 2006). To address both these issues, I engineered a 
Mad1 construct which, unlike endogenous Mad1, localizes to kinetochores that are 
bioriented. In this Chapter, I show that Mad1’s constitutive localization at kinetochores 
is sufficient for a metaphase arrest that depends on Mad1-Mad2 binding. By uncoupling 
the checkpoint from its primary error signal, I show that Aurora kinase, Mps1 and 
BubR1, but not Polo-like kinase, are needed to maintain the checkpoint arrest even 
when Mad1 is present on bi-oriented kinetochores. Together, my data suggest a model 
in which the biorientation errors, which recruit Mad1-Mad2 to kinetochores, may be 
signaled not only through Mad2’s templated activation dynamics, but also through the 
activity of widely conserved kinases, to ensure the fidelity of cell division. 
Rationale 
The spindle assembly checkpoint, which can block anaphase when even a single 
chromosome is improperly attached to spindle microtubules, depends on Mad1 and 
Mad2 (Musacchio and Salmon, 2007). In current models of checkpoint signaling, a key 
step is the recruitment of Mad1 and Mad2 to kinetochores that lack proper microtubule 
attachments. Mad1 forms a homodimer that binds two Mad2 molecules, forming a 
“core tetramer”, which “templates” the conversion of cytosolic Mad2 from an inactive 
“open” conformation to a “closed” form (Fig. 2.1; Sironi et al., 2002; Luo and Yu, 2008;).  
A diffusible cytosolic complex, which includes closed-Mad2, blocks anaphase 
progression by inhibiting the activation of APC/C, the E3 ubiquitin ligase required for 
anaphase (Musacchio and Salmon, 2007; Hardwick et al., 2000; Sudakin et al., 2001). 
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The binding of microtubules to the kinetochore removes Mad1-Mad2 and thereby 
suppresses the generation of closed-Mad2 (Fig. 2.1; Musacchio and Salmon, 2007). As 
Mad1, unlike Mad2, is not expected to undergo conformational dynamics at kinetochore 
sites (Sironi et al., 2002; Luo and Yu, 2008) and is not a component of the soluble 
complex that inhibits APC/C activation (Hardwick et al., 2000; Sudakin et al., 2001), we 
envisioned that engineering the constitutive localization of Mad1 to kinetochores may 








Figure 2.1 Experimental design to recruit Mad2 to kinetochores independently of 
microtubule attachment. (a) Endogenous Mad1 (grey) localizes to kinetochores that are 
not attached to microtubules and recruits Mad2 (dark green), forming a Mad1-Mad2 
core tetramer. The Mad1-bound Mad2 catalytically converts open-Mad2 molecules 
(dark green square) into closed-Mad2 molecules (dark green circle). Microtubule (light 
green) binding displaces Mad1, and therefore Mad2, from kinetochores. (b) We fused 
Mad1 to Mis12 (red), a protein whose kinetochore localization is microtubule-binding 




Constitutive kinetochore localization of Mad1 induces Mad2-dependent 
checkpoint arrest 
To localize Mad1 at all kinetochores, I considered fusing it to Mis12, a kinetochore 
resident protein and member of the KMN complex, a core component of the outer 
kinetochore (Cheeseman et al., 2004). Since KMN proteins are implicated in recruiting 
endogenous Mad1 to kinetochores (Santaguida and Musacchio, 2009), I reasoned that 
engineered fusion constructs could be designed to achieve a kinetochore localization of 
Mad1 similar to the endogenous one, but independent of kinetochore-microtubule 
attachment. A fusion construct with an N-terminal mCherry tag, followed by a flexible 
linker, Mis12, a second flexible linker and Mad1 at the C-terminus— such that 
interactions with Mad2 would likely remain unaffected— was found to express at levels 
that were similar to endogenous Mad1 (Fig. 2.2a). In live cells, I found that mCherry-
Mis12-Mad1 localized to puncta on the chromosomes, as would be expected for a 
kinetochore-targeted protein, in mitotic and interphase cells (Fig. 2.2b). Unlike 
endogenous Mad1, this signal was observed on chromosomes at the metaphase plate, 
suggesting that the fusion construct localized at properly bioriented chromosomes. In 
addition, immunofluorescence analysis of CREST and tubulin signals in fixed cells 
revealed the robust localization of mCherry-Mis12-Mad1 at outer kinetochores that 
were aligned at the metaphase plate and had microtubule bundles with intensities 
similar to that of control mitotic cells (Fig. 2.2c-e). To visualize interactions between 
mCherry-Mis12-Mad1 and Mad2 in live cells, I generated a HeLa cell line that stably 
expresses GFP-Mad2 and transiently transfected it with mCherry-Mis12-Mad1. I 
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incubated these cells in the proteosome inhibitor MG132, such that metaphase spindles 
would accumulate and the endogenous Mad1 would be removed from the 
kinetochores. Live imaging revealed that GFP and mCherry signals co-localized on all 
chromosomes of the mCherry-positive cells, even if they had tight metaphase plates 
that persisted for hours (Fig. 2.2f-g). These results show that fusion of Mad1 to Mis12 
achieves constitutive kinetochore localization of Mad1 and Mad2, regardless of 









Figure 2.2 A mCherry-Mis12-Mad1 fusion can recruit Mad2 to kinetochores 
independently of microtubule attachment. (a) The expression levels of mCherry-Mis12-
Mad1, mCherry-Mis12-Mad1 K541A L543A (AA) and mCherry-Mad1 (upper bands) are 
similar to the levels of endogenous Mad1 (lower bands), by immunoblotting. (b) 
Analysis of mCherry-Mis12-Mad1 localization in live cells. Differential interference 
contrast (DIC) and mCherry-fluorescence images of a mCherry-Mis12-Mad1-transfected 
cell at metaphase. (c-e) mCherry-Mis12-Mad1 localizes at kinetochores, even when they 
are attached to microtubules.  Immunofluorescence images of HeLa (control) (c) and 
mCherry-Mis12-Mad1-transfected (d) cells, stained for DNA, tubulin, CREST and 
mCherry. Overlay shows tubulin (green), CREST (blue) and mCherry (red). Insets 
(selected optical sections) (e) show individual microtubule-attached kinetochores from 
(d), 5-fold magnification. (f) Analysis of Mad2 recruitment by mCherry-Mis12-Mad1. DIC, 
mCherry- and GFP-fluorescence images of a HeLa cell stably-expressing GFP-Mad2, 
transfected with mCherry-Mis12-Mad1 are shown. MG132 (10 μM, 1 h) was used to 
accumulate live cells at metaphase with many microtubule-attached chromosomes. (g) 
The metaphase arrest induced by mCherry-Mis12-Mad1 is persistent. Live mCherry-
fluorescence images of a mCherry-Mis12-Mad1-transfected HeLa cell at metaphase are 















I then investigated the effects of the constitutively kinetochore-localized Mad1-
Mad2 on cell cycle progression. Compared to untransfected control cells, I observed a 
~5-fold increase (27.6% ± 2%) in the mitotic index of the mCherry-positive cells, 24 h 
post-transfection. Of these mitotic cells, 95.6% (± 1.7%) were at metaphase (Fig. 2.3a). 
Thirty hours after transfection, the mitotic index of the mCherry-Mis12-Mad1-
transfected population increased to 43% (± 6.2%), indicating that this metaphase arrest 
was persistent. Similar results were found with live imaging experiments (Fig. 2.2g). In 
addition, mCherry-Mis12-Mad1 transfected into immortalized RPE-1 cells also resulted 
in a persistent metaphase arrest (Fig. 2.3b). To confirm that the increased mitotic index 
seen in mCherry-Mis12-Mad1-transfected cells was not caused by overexpression of 
Mad1 alone, I transfected cells with mCherry-Mad1.  This construct was expressed at 
levels similar to that of mCherry-Mis12-Mad1 (Fig. 2.2a), and the transfected population 
did not show an increase in the mitotic index (Fig. 2.3c). This suggests that it is the 
kinetochore targeting of the forced-localized Mad1, and hence Mad2, that is responsible 




Figure 2.3 Constitutive kinetochore localization of Mad1 causes a persistent, Mad2-
dependent metaphase arrest. (a) Analysis of mitotic index and phenotypes in HeLa, 
mCherry-Mis12-Mad1- and mCherry-Mis12-Mad1 AA- transfected cells. Cells were fixed 
24 h and 30 h after transfection. (b) Analysis of mitotic index of mCherry-Mis12-Mad1- 
and mCherry-Mis12-Mad1 AA- transfected, or untransfected RPE-1 cells. Cells were 
fixed 48 h after transfection. (c) Analysis of mitotic index in mCherry-Mad1-transfected 
and untransfected HeLa cells. Cells were fixed 24 h after transfection. For (a-c), 
mCherry, tubulin and DNA staining (not shown) was used to determine mitotic index 
and fraction of cells in metaphase, anaphase and all other mitotic states (n= 3 
independent experiments, > 400 cells counted per condition per time). (d) The increase 
in mitotic index induced by mCherry-Mis12-Mad1 is Mad2-dependent. HeLa cells were 
transfected with small-interfering RNA against Mad2 or GFP, 24 h before transient 
transfection with mCherry-Mis12-Mad2 or mCherry-Mis12-Mad1-AA, or no transfection. 
Mitotic indices were determined after another 24 h (n= 3 independent experiments, > 
250 cells counted per condition per time). (e-g) mCherry-Mis12-Mad1 AA localizes at 
kinetochores in interphase (e), metaphase (f) and anaphase (g). Staining for DNA, 
tubulin, CREST and mCherry is shown. (h) mCherry-Mis12-Mad1 AA does not prevent 
the completion of mitosis. mCherry fluorescence images of a live cell are shown. The 
indicated times (min) are relative to the first frame (prometaphase). (i-k) Expression of 
mCherry-Mis12-Mad1 and mCherry-Mis12-Mad1 AA are similar, by quantification of 
normalized, corrected fluorescence levels of mCherry by immunoblotting (n= 3 
independent experiments) (i), of mCherry in whole cells by live imaging (n= 2 
independent experiments, > 14 cells counted per condition per time) (j) and of mCherry 
at individual kinetochores by immunofluorescence (n= 2 independent experiments, > 3 
kinetochores counted per cell, 69 kinetochores per condition in total) (k). (l-m) mCherry-
Mis12-Mad1-AA localizes at kinetochores, but does not recruit GFP-Mad2. mCherry- (l) 
and GFP- (m) fluorescence images of a mCherry-Mis12-Mad1-AA transfected cell at 
metaphase. MG132 (10 μM, 1 h) was used to accumulate live cells at metaphase with 






Next, I analyzed whether this mitotic index increase was a bona fide, Mad2-
dependent checkpoint arrest in two ways. First, I used RNA interference (RNAi) to 
deplete Mad2. I observed a significant decrease in the mitotic index of the mCherry-
Mis12-Mad1 population upon transfection with Mad2 siRNA (two-tailed T-test, p=0.026; 
Fig 2.3d). Second, I used a Mad1 K541A L543A mutant construct (hereafter, mCherry-
Mis12-Mad1 AA), which does not interact with Mad2 owing to mutations in the Mad2-
binding motif (Sironi et al., 2002). I found that the mCherry-Mis12-Mad1 AA fusion 
localized at kinetochores both in mitotic and interphase cells (Fig. 2.3e-h) and expressed 
at similar levels to those of mCherry-Mis12-Mad1 (Fig. 2.2a, 2.3i-k). As expected, I did 
not detect co-localization of mCherry-Mis12-Mad1 AA and GFP-Mad2 (Fig. 2.3l-m). The 
mitotic index of cells transfected with this “mutant” construct was 12.7% (± 1.7%; Fig. 
2.3a), which was significantly different from mCherry-Mis12-Mad1-transfected cells 
(two-tailed T-test, p=0.005). Moreover, mCherry-Mis12-Mad1 AA-positive cells divided 
without appreciable chromosome segregation defects (Fig. 2.3g-h). Together, these 
results indicate that the increase in the mitotic index resulting from mCherry-Mis12-
Mad1 expression is dependent on Mad2-binding.   
Mis12-Mad1 does not induce overt alterations in kinetochore structure or 
function 
I then examined if the prolonged mitotic arrest was due to indirect effects on 
kinetochore structure and kinetochore-microtubule binding. First, I used cold treatment 
to analyze the stability of kinetochore-microtubule attachments in mCherry-Mis12-
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Mad1 and -Mad1-AA- expressing cells. Immunofluorescence showed the presence of 
cold-stable kinetochore-microtubule bundles, with co-localizing mCherry and CREST 
signals at the kinetochore ends (Fig. 2.4c-f). These cold-stable microtubules had 




Figure 2.4 Analysis of cold-stable microtubules shows that forced kinetochore 
localization of Mad1 does not disrupt microtubule attachment. HeLa (a), mCherry-
Mis12-Mad1- (c) or mCherry-Mis12-Mad1-AA-transfected (e) cells were incubated in 
MG132 (10 μM, 1 h) to accumulate cells at metaphase and were then placed on ice (10 
min) before fixation. Cells were stained for DNA, CREST (blue), mCherry (red) and 
tubulin (green).  Individual channels and an overlay are shown. Insets (selected optical 
sections) (b, d, f) show individual cold-stable microtubule-attached kinetochores (4-fold 
magnification). Scale bar, 5 μm.    
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Next, I analyzed the localization of p150Glued, CENP-E, Bub1, ROD and ZW10— 
checkpoint proteins that reside at the kinetochore corona. Since kinetochore assembly 
is hierarchical, correct recruitment of corona components suggests proper kinetochore 
assembly (Cheeseman et al., 2004; Cheeseman and Desai, 2008). These checkpoint 
proteins are recruited to kinetochores that have not yet bioriented and are completely 
or partially removed from those sites upon biorientation, in unperturbed mitotic cells 
(Musacchio and Salmon, 2007; Hoffman et al., 2001; Karess, 2005). I first exposed the 
cells to the microtubule depolymerizing drug nocodazole to suppress biorientation. 
P150Glued, CENP-E, Bub1, Rod and ZW10 were all seen on unattached kinetochores, both 
in mCherry-Mis12-Mad1-expressing and control cells (Fig. 2.5a-e, first to third columns). 
Additionally, p150Glued and CENP-E recruitment was also undisrupted in nocodazole-
treated mCherry-Mis12-Mad1 AA-transfected cells (Fig. 2.5f-g). I then examined the 
localization of these proteins on otherwise unperturbed, bioriented mCherry-Mis12-
Mad1-positive kinetochores. Immunofluorescence revealed that the removal (or 
reduction) of each of these proteins was consistent with published data on their 
localization on bioriented chromosomes (Fig. 2.5a-e, fourth and fifth columns). 
Together, these data suggest that there are no overt dominant-negative effects on 











Figure 2.5 Analysis of localization of checkpoint proteins in cells with mCherry-Mis12-
Mad1 shows that forced kinetochore localization of Mad1 does not disrupt 
kinetochore structure. (a-g) HeLa, mCherry-Mis12-Mad1- (a-e) and mCherry-Mis12-
Mad1-AA- (f, g) transfected cells were incubated in nocodazole (1 μg ml-1, 45 min; a-e 
first to third columns; f, g) or left unperturbed (a-e fourth and fifth columns). Cells were 
stained for DNA, CREST, mCherry and the relevant checkpoint protein. 
Immunofluorescence images show staining for mCherry and p150Glued (a, f), CENP-E (b, 








Constitutive localization of Mad1 to non-kinetochore locations does not 
induce checkpoint arrest 
Next, I examined whether it was the kinetochore location of Mad1 that was necessary 
for such an arrest, by force-localizing Mad1 to two different chromosomal locations. 
First, I mis-localized Mad1 all along chromosomes by fusing it to histone H2B. The 
mCherry-H2B-Mad1 fusion showed the expected localization (Fig. 2.6a-i) and did not 
have dominant-negative effects (Fig. 2.6d-e). mCherry-H2B-Mad1-expressing cells were 
able to undergo anaphase normally (Fig. 2.6h-i) and the mitotic index of this population 
was indistinguishable from that of the control (Fig. 2.6j; two-tailed T-test, p=0.20). To 
confirm that, despite not having apparent mitotic effects, mCherry-H2B-Mad1 indeed 
interacted with Mad2, I transfected the construct into the GFP-Mad2 line. I found that 
mCherry-H2B-Mad1 and GFP-Mad2 co-localized throughout all chromosomes in 
interphase and mitosis, including anaphase (Fig. 2.6k-p). This suggests that 






Figure 2.6 Forced localization of Mad1 to chromosome arms by fusion to H2B recruits 
Mad2, but does not affect mitosis. HeLa cells (a-e) or HeLa cells stably expressing GFP-
Mad2 (f-p) were transfected with mCherry-H2B-Mad1 and processed 48 h later. (a) GFP-
Mad2 co-localizes with mCherry-H2B-Mad1 throughout chromosome arms. 
Immunofluorescence images of a chromosome spread show staining for DNA, mCherry 
and GFP. (b) mCherry-H2B-Mad1-transfected cells were incubated in nocodazole (1 
μg/ml, 45 min) and stained for DNA, mCherry, CREST and CENP-E. Insets (selected 
optical sections) (c) show various kinetochores where CENP-E crescents are observed (4-
fold magnification). (d) Analysis of cold-stable microtubules. mCherry-H2B-Mad1-
transfected cells were incubated in MG132 (10 μM, 1 h) to accumulate cells at 
metaphase and were then placed on ice (10 min) before fixation. Cells were stained for 
DNA, CREST, mCherry and tubulin Insets (selected optical sections) (e) show individual 
cold-stable microtubule-attached kinetochores (4-fold magnification). (f-p) Expression of 
mCherry-H2B-Mad1 does not affect mitotic progression. DIC (f, h, k, n), mCherry- (g, i, l, 
o) and GFP-fluorescence (m, p) images of an interphase cell (f, g), a prometaphase cell 
(k-m) and a cell undergoing anaphase (h, i, n-p) are shown. (j)  Mitotic indices were 
calculated by analyzing mCherry, tubulin and DNA staining (n= 3 independent 
experiments, > 350 cells counted per condition per time). Scale bar, 5 μm. Average ± 








Second, I mis-localized Mad1 at centromeres, via fusion with CENP-B’s centromere-
targeting domain. Unexpectedly, this fusion protein had deleterious effects on 
kinetochore-microtubule attachments (Fig. 2.7a-g). Although some cells achieved 
apparent biorientation, live-cell imaging revealed that the majority of these metaphase 
plates subsequently became mis-aligned, or transitioned into anaphase with numerous 
lagging chromosomes (Fig. 2.7h-i). Therefore, the use of this construct to dissect 
checkpoint signaling from chromosome biorientation was unfeasible. Together, these 
data suggest that the kinetochore represents a specialized chromosomal location for 







Figure 2.7 Fusion of Mad1 to CENP-B’s centromere targeting domain has deleterious 
effects on microtubule attachment. (a-c) mCherry-CENP-B(aminoacids 1-158)-Mad1 
localizes at centromeres in interphase (a) and mitotic (b, c) transfected HeLa cells. 
Mitotic cells with aligned (b) and misaligned chromosomes (c) are shown. 
Immunofluorescence images show staining for DNA, tubulin, CREST and mCherry. (d) 
Mitotic index of HeLa and mCherry-CENP-B-Mad1-transfected cells. (e) Comparison of 
abnormal mitotic phenotypes in HeLa, mCherry-Mis12-Mad1-, mCherry-Mis12-Mad1 
AA- and mCherry-CENP-B-Mad1-transfected cells. mCherry, tubulin and DNA staining 
was used to calculate mitotic index and fraction of cells with multipolar spindles and 
misaligned chromosomes (n= 4 independent experiments, > 100 mitotic cells counted 
per condition per time). (f-g) Analysis of cold-stable microtubules. mCherry-CENP-B-
Mad1 transfected cells were incubated in MG132 (10 μM, 1 h) to accumulate cells at 
metaphase and were then placed on ice (10 min) before fixation. Immunofluorescence 
images show staining for DNA, CREST, mCherry and tubulin, for two example cells. (h-i) 
Mitotic time-lapses of cells expressing mCherry-CENP-B-Mad1. Two example cells are 
shown where chromosomal alignment is transiently achieved before gross mis-
alignment (h) or mis-segregation in anaphase (i). DIC and mCherry channels are shown. 










Using Mis12-Mad1 as a tool to examine kinase contributions to checkpoint 
signaling  
Positive and negative “control” kinases 
Next, I used the kinetochore-localized Mad1 constructs to dissect the roles of 
checkpoint kinases in maintaining checkpoint arrest. Forced kinetochore-localization of 
Mad1 allows us to bypass the need for Mad1 and Mad2 recruitment to the kinetochore 
to establish checkpoint arrest and hence to dissect the requirements of checkpoint 
signaling upstream and downstream of Mad1/Mad2 recruitment. If activity of a 
checkpoint kinase were needed upstream Mad1/Mad2 recruitment, forced localization 
of Mad1 should bypass the need for such activity, and inhibition of the kinase should 
not alter the checkpoint arrest caused by Mis12-Mad1. On the other hand, if kinase 
activity were needed downstream of Mad1/Mad2 recruitment in order to maintain the 
checkpoint arrest, then inhibition of kinase activity should abrogate the arrest and cause 
a reduction in the mitotic index, regardless of the forced localization of Mad1. 
 I first examined the contributions of BubR1, a conserved cell cycle kinase that 
regulates kinetochore-microtubule attachment (Musacchio and Salmon, 2007), that has 
roles as a kinetochore-independent “timer” that sets the length of mitosis (Meraldi et 
al., 2004a) and that is also a component of the soluble complex that inhibits APC/C-
cdc20 (Sudakin et al., 2001). Because of these functions, I predicted that BubR1 
inhibition would override the arrest induced by mCherry-Mis12-Mad1. Owing to the lack 
of available BubR1 chemical inhibitors, I depleted the kinase with RNAi. Knockdown led 
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to a significant reduction in the mitotic index (two-tailed T-test, p=0.013) and an 
increase in the percentage of anaphase cells of the mCherry-Mis12-Mad1 population 
(Fig. 2.8a). Together with previous studies (Musacchio and Salmon, 2007; Sudakin et al., 
2001; Meraldi et al., 2004a), our findings are consistent with BubR1 being necessary for 
checkpoint signaling downstream of Mad1-Mad2.  
I then used this assay to examine the contributions of Polo-like kinase (Plk1) to 
checkpoint signaling. Plk1 is another widely conserved, cell cycle kinase involved in a 
variety of cell-cycle processes, including the regulation of kinetochore-microtubule 
attachments (Petronczki et al., 2008). Inhibition of Plk1 activity with its selective 
inhibitor BI2536 did not result in a reduction of the mitotic index of the mCherry-Mis12-
Mad1 population, or in the appearance of anaphase cells (Fig. 2.8b). These findings are 
consistent with other studies of Polo-like kinases (Petronczki et al., 2008) and show that, 
although Plk1 is required for the regulation of chromosome biorientation, it is not 












Figure 2.8 Inhibition of BubR1, but not of Plk1, is sufficient for entry into anaphase in 
cells expressing mCherry-Mis12-Mad1.(a-b) Analysis of mitotic index and phenotypes in 
HeLa (control), mCherry-Mis12-Mad1- and mCherry-Mis12-Mad1 AA- transfected cells 
upon BubR1 depletion (a) or Polo-like kinase (b). Cells were transfected with siRNA 
against GFP (control) or BubR1 (a), or incubated in DMSO, BI2536 (80 nM, 90 min before 
fixation) (b). mCherry, tubulin and DNA staining was used to calculate mitotic index and 
fraction of cells in metaphase, anaphase and all other mitotic states (a) or with 
monopolar spindles, in anaphase or all other mitotic states (b) (n= 3 independent 
experiments, > 350 cells counted per condition per time). Average ± s.e.m. shown.  
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Kinases potentially directly involved in checkpoint signaling 
Next, I used our assay to dissect the requirement for Mps1 and Aurora B in the 
maintenance of the checkpoint arrest. Both of these conserved kinases are involved in 
the recruitment of key checkpoint components to unattached kinetochores and in the 
regulation of the correction of erroneous microtubule attachments for the attainment 
of biorientation, in a variety of organisms (Meraldi et al., 2004b; Lan and Cleveland, 
2010). Although some discrepancies exist, current models agree that Aurora B and Mps1 
act in a common network of mitotic signaling (Lan and Cleveland, 2010; Saurin et al., 
2011). Mps1 accumulates at unattached kinetochores, and biorientation depletes the 
kinase from kinetochores (Jelluma et al., 2010). Recent findings suggest that Mps1 has 
cytosolic as well as kinetochore-specific functions (Maciejowski et al. 2010; Lan and 
Cleveland, 2010). I reasoned that our assay would allow us to examine the requirement 
for cytosolic Mps1 in maintaining the checkpoint arrest when chromosomes are 
bioriented, and therefore independently of its kinetochore functions. To do this, I used 
two unrelated Mps1 inhibitors—Mps1-IN-1 (Kwiatkowski et al. 2010) and reversine 
(Santaguida et al. 2010)—in parallel experiments, to reduce the likelihood of 
overlapping off-target effects of either inhibitor. After a two-hour incubation with 
Mps1-IN-1, the mCherry-Mis12-Mad1 population showed a significant reduction in 
mitotic index (Fig. 2.9a; two-tailed T-test, p=0.0069) and a corresponding increase in 
anaphase cells (two-tailed T-test, p=0.0081). Similar results were obtained using 
reversine (Fig. 2.9b). I confirmed these results at a single-cell level, by following 
mCherry-Mis12-Mad1 metaphase cells after inhibitor addition, using live imaging (Fig. 
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2.9c-p). By 70 minutes after the Mps1-IN-1 wash-in, ~50% of the mCherry-Mis12-Mad1 
cells that were initially at metaphase entered anaphase (Fig. 2.9o). Similarly, ~50% of 
the metaphase mCherry-Mis12-Mad1 cells entered anaphase ~75 minutes after 
reversine wash-in (Fig. 2.9p). Importantly, no lagging chromosomes were seen in the 
anaphase cells, either in the live- or fixed-cell experiments with either Mps1 inhibitor, 
supporting our observations that chromosomes are properly bioriented in the presence 
of mCherry-Mis12-Mad1. These results indicate that cytosolic activities of Mps1 are 













Figure 2.9 Inhibition of Mps1 is sufficient for entry into anaphase, even when Mad1 
persists at kinetochores. (a-b) Analysis of mitotic index and phenotypes in HeLa 
(control), mCherry-Mis12-Mad1- and mCherry-Mis12-Mad1 AA- transfected cells upon 
Mps1 inhibition. Cells were incubated in DMSO, Mps1-IN-1 (10 μM, 80 min) (a) or 
reversine (500 nM, 120 min) before fixation (b). mCherry, tubulin and DNA staining was 
used to calculate mitotic index and fraction of cells in metaphase, anaphase and all 
other mitotic states (n= 3 independent experiments, > 350 cells counted per condition 
per time). (c-p) Analysis of the effects of inhibition of Mps1 in live mCherry-Mis12-
Mad1-transfected cells.  Metaphase mCherry-positive cells were selected before the 
medium was changed to one containing DMSO, Mps1-IN-1 (10 μM) or reversine (500 
nM; n= 3 independent experiments, > 10 cells per condition per experiment). Each of 
those cells was imaged by multi-point re-visiting using microscope software. DIC (c, d, g, 
h, k, l) and mCherry-fluorescence (e, f, i, j, m, n) images at the indicated times before 
and after Mps1-IN-1 or reversine wash-in are shown. (o, p) Cumulative frequency of the 
imaged cells entering anaphase after Mps-IN-1 (o) or reversine (p) wash-in. Scale bar, 5 










Next, I examined the role of Aurora B kinase in directly maintaining checkpoint 
arrest, independently of its upstream functions in kinetochore assembly and error 
correction (Meraldi et al., 2004b). I incubated mCherry-Mis12-Mad1-transfected cells in 
the Aurora B small-molecule inhibitor ZM447439 (Ditchfield et al., 2003). The mCherry-
Mis12-Mad1 population showed a significant reduction in its mitotic index (Fig. 2.10a; 
two-tailed T-test, p=0.016) and in the percentage of metaphase cells (two-tailed T-test, 
p=0.0069) and, more importantly, a significant increase in the percentage of anaphase 
cells (two-tailed T-test, p=0.018). The intensity of the mCherry-Mis12-Mad1 signals was 
not reduced in the segregating chromosomes, ruling out the possibility that Aurora 
inhibition merely removed the construct from the bioriented kinetochores (data not 
shown). Similar results were obtained when I inhibited Aurora B with a different 
inhibitor (hesperadin; Hauf et al., 2003; Fig. 2.10b, g-j, l). I confirmed these results at a 
single-cell level with live imaging: 80 minutes after the addition of ZM447439 or 
hesperadin, ~50% of the mCherry-Mis12-Mad1 cells that were initially at metaphase 
transitioned to anaphase (Fig. 2.10c- l). Lagging chromosomes during anaphase were not 
observed in our experiments, with either of the two inhibitors. These results 
corroborate our fixed-cell analyses that inhibition of Aurora B activity is sufficient for 
overriding the checkpoint, despite retention of Mad1 on kinetochores (Fig. 2.10f, j). A 
recent study has shown that constitutive kinetochore localization of Mps1 also results in 
a persistent mitotic arrest, but that inhibition of Aurora activity does not induce 
anaphase entry in this case (Jelluma et al. 2010). This can be explained by the fact that 
Mps1 force-localized at bioriented kinetochores may access substrates that, under 
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normal conditions or in the presence of the Mis12-Mad1 fusion, it would not. Together 
with these data, our findings suggest that Mps1 must be released from kinetochores for 
Aurora inhibition to exert its anaphase-promoting effect. Further, our data indicate that 
Aurora B activity is needed for maintenance of checkpoint arrest in human cells, 












Figure 2.10 Inhibition of Aurora B is sufficient for entry into anaphase, even when 
Mad1 persists at kinetochores. (a-b) Analysis of mitotic index and phenotypes in HeLa 
(control), mCherry-Mis12-Mad1- and mCherry-Mis12-Mad1 AA- transfected cells upon 
Aurora B inhibition. Cells were incubated in DMSO, ZM447439 (2 μM, 60 min) (a) or 
hesperadin (50 nM, 90 min) before fixation (b). mCherry, tubulin and DNA staining was 
used to calculate mitotic index and fraction of cells in metaphase, anaphase and all 
other mitotic states (n= 3 independent experiments, > 350 cells counted per condition 
per time). (c-l) Analysis of the effects of inhibition of Aurora B in live mCherry-Mis12-
Mad1-transfected cells.  Metaphase mCherry-positive cells were selected before the 
medium was changed to one containing DMSO, ZM447439 (2 μM) or hesperadin (50 
nM; n= 3 independent experiments, > 10 cells per condition per experiment). Each of 
those cells was imaged by multi-point re-visiting using microscope software. DIC (c, d, g, 
h) and mCherry-fluorescence (e, f, i, j) images at the indicated times before and after 
ZM447439 or hesperadin wash-in are shown. (k, l) Cumulative frequency of the imaged 
cells entering anaphase after ZM447439 (k) or hesperadin (l) wash-in. Scale bar, 5 μm. 










Conclusions and discussion 
In this Chapter, I showed that the recruitment of Mad1 and Mad2 to kinetochores via 
the fusion of Mad1 to Mis12 is sufficient for the establishment of a checkpoint arrest, 
regardless of chromosome biorientation. On the contrary, recruitment of Mad1 to non-
kinetochore chromosomal locations via the fusion to CENP-B or H2B did not elicit a 
checkpoint arrest independently of the status of microtubule attachment. In other 
words, the kinetochore recruitment of Mad1 and Mad2 is sufficient for checkpoint 
arrest, but whether this recruitment is also necessary is still unclear (further discussed in 
Chapter 4). Using the Mis12-Mad1 construct to uncouple checkpoint signaling from 
chromosome biorientation, I was able to assay the requirement for kinase activity in the 
maintenance of checkpoint arrest independently of their “upstream”, indirectly 
necessary functions. I showed that Mps1 and Aurora B activities are bona fide 
checkpoint signaling components downstream of Mad1 and Mad2 kinetochore 
recruitment. 
The spindle assembly checkpoint must maintain anaphase inhibition until 
biorientation of every chromosome is achieved. This requires the continuous generation 
of the “wait” signal at levels such that even one mal-oriented kinetochore can block 
progression (Rieder et al., 1994; Musacchio and Salmon, 2007). The Mad2-template 
model of checkpoint signaling provides an attractive framework for how Mad1 and 
Mad2 can detect the primary error and continuously produce the biochemical 
anaphase-inhibitory signal, even when those proteins do not have canonical enzymatic 
activities (Luo and Yu, 2008; Simonetta et al., 2009). Nevertheless, several kinases, 
61 
 
which as enzymes can phosphorylate multiple substrate molecules to generate a 
biochemically amplifiable signal, are believed to play a crucial role in the checkpoint 
(Burke and Stukenberg, 2008; Kang and Yu, 2009). However, examining their 
contribution to checkpoint establishment and maintenance had been difficult, especially 
because many of these kinases have essential functions in preceding steps needed for 
successful mitosis. This is particularly relevant for Aurora B kinase. It has been proposed 
that inhibition of Aurora leads to checkpoint silencing indirectly, due to the consequent 
stabilization of all improper attachments, which leads to the removal of Mad1-Mad2 
from the kinetochores and hence to suppression of the primary error signal (Ditchfield 
et al., 2003; Hauf et al., 2003; Pinsky et al., 2006). Nevertheless, experiments involving 
Aurora inhibition together with the use of microtubule poisons suggest that Aurora is 
directly required for maintaining mitotic arrest (Ditchfield et al., 2003; Hauf et al., 2003; 
Emanuele et al., 2008; Kallio et al., 2002; Petersen and Hagan, 2003; Vanoosthuyse and 
Hardwick, 2009). The override of the arrest seen there has been difficult to interpret 
because prolonged arrest in high concentrations of Aurora inhibitors may disrupt 
kinetochore assembly (Emanuele et al., 2008) and may also accumulate chemical 
inhibitor’s off-target effects in vertebrates. Therefore, dissecting the contributions of 
key cell cycle kinases (e.g. Aurora B) has remained challenging. 
Using our constitutively-kinetochore-localized Mad1 assays, I was able to show in 
human cells that Aurora activity is directly required for the maintenance of checkpoint 
arrest. While it is difficult to rule out more complex models, I favor the hypothesis that 
Aurora kinase is acting downstream of Mad1-Mad2 recruitment. Together with findings 
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from others (Lan and Cleveland, 2010; Santaguida et al. 2011), our data suggest a model 
in which the APC/C-inhibitory signal is maintained not only by Mad2-templated 
dynamics, but also by Aurora kinase and cytosolic Mps1. Because in our assays cells 
arrest in mitosis with bioriented chromosomes, our results suggest that this signaling 
pathway is likely independent of mechanisms requiring the spatial separation of 
kinetochore substrates from centromeric Aurora (Liu et al., 2009). Finding the relevant 
molecular links between Aurora, Mps1 and the APC/C is an important next step. I 
speculate that the MCC, the APC/C, p31/Comet and other poorly characterized 
checkpoint silencing factors might be the relevant substrates. In fact, Mps1 
phosphorylation sites on C-Mad2 necessary for checkpoint arrest maintenance have 
recently been found (Zich et al. 2012).  However, based on how challenging it has been 
to find physiologically relevant mitotic kinase substrates, I anticipate that finding the 
complete set of substrates will be a substantial undertaking. It is likely that our 
constitutive kinetochore-localized Mad1 assay will be useful for these analyses.  
It has recently been shown in vitro that chromosomes are not only required to 
generate the APC/C-inhibitory signal, but are also capable of catalyzing its production 
(Kulukian et al., 2009). Together with these data, our findings that recruitment of Mad1-
Mad2 to the kinetochore– but not throughout chromosomes– is needed to induce 
mitotic arrest, suggest a model in which the local kinetochore environment is crucial for 
generating the signal that will block anaphase when even a single chromosome remains 
non-bioriented. Advances in high-resolution microscopy have built on a large body of 
genetic and biochemical data to reveal the kinetochore architecture at nanometer 
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resolution (Wan et al., 2009). Going forward, it will be important to dissect how the local 




Chapter 3: Characterizing the 
effects of ciliobrevin D— the first 
specific, small-molecule dynein 
inhibitor— in mitotic cells 
Summary 
Accurate chromosome segregation depends on proper spindle assembly, which allows 
for biorientation of kinetochores and progression into anaphase (Musacchio and 
Salmon, 2007). Proper spindle assembly and function depend on the activity of motor 
and non-motor microtubule-associated proteins that regulate microtubule 
polymerization and depolymerization dynamics, cross-linking of microtubules at the 
poles and chromosome-microtubule interactions at the kinetochores (Wadsworth et al., 
2011). The minus-end-directed microtubule-based motor protein dynein, a member of 
the AAA+ protein family (ATPases associated with a variety of cellular activities), has 
activities both at the spindle poles and at the kinetochore-microtubule interface and 
plays important roles in proper spindle assembly (Vaisberg et al., 1993; Merdes et al., 
1996; Erzberger and Berger, 2006). However, dynein’s functions remain incompletely 
understood due to the paucity of robust molecular tools for its study. In particular, no 
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specific cell-permeable, acute, small molecule inhibitors—which would help further 
dissect the motor-protein’s roles in spindle assembly and checkpoint silencing—had 
been described prior to the work by Firestone et al. (2012), to which I contributed as 
detailed below. 
In this Chapter, I present work on “ciliobrevin D”, the small molecule discovered 
by Dr James Chen and colleagues (Stanford University) that is the first specific dynein 
inhibitor. I characterize its effects on mitotic cells and I describe how, in agreement with 
known dynein functions, ciliobrevin D reversibly disrupts spindle bipolarity and the 
integrity of kinetochore-microtubule interactions. Using ciliobrevin D, I uncover a new 
role of dynein in spindle morphogenesis: dynein is involved not only in the 
establishment of bipolarity, but also in its maintenance. The ciliobrevin family of 
compounds will be valuable tools in the study of dynein roles in other mitotic and 
interphase investigations and may also guide the development of specific inhibitors of 
other AAA+ family members involved in a myriad of cellular and clinically relevant 
processes. 
Introduction 
Dynein structure, function and behaviour 
Dynein is a molecular motor of the AAA+ ATPase family that couples ATP hydrolysis to 
movement towards the minus end of microtubules (Hughes et al., 1995). There are 
three main dynein subfamilies, whose members are involved in a variety of cellular 
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mechanisms (Hook and Vallee, 2006). At the axoneme, axonemal dynein is involved in 
coordinating the beating of flagella and cilia (King, 2012). Cytoplasmic dynein 2 carries 
out retrograde (minus-end-directed) intraflagellar transport and is necessary for 
axoneme biogenesis and Hedgehog signaling, among other roles (Blacque et al., 2008; 
Pazour et al., 1998). Cytoplasmic dynein 1, the most abundant of dyneins, is present in 
all microtubule-containing cells in the cytoplasm, cell cortex and kinetochores (Dujardin 
and Vallee, 2002; Bader and Vaughan, 2010). Cytoplasmic dynein 1 is responsible for the 
minus-end directed movement of a wide array of cargoes: proteins (e.g. the checkpoint 
proteins Mad1, Mad2; Howell et al., 2001), mRNA (e.g. the embryonic factors bicoid, 
gurken and oskar; Bullock et al., 2006) and vesicles (e.g. Golgi particles, endosomes, 
synaptic vesicles; Hunt and Stephens, 2011). As such, it is involved in diverse processes 
such as embryogenesis, cell migration, Golgi morphology, neural axon polarization, 
nerve regeneration and mitosis, among others.  
Functional cytoplasmic dynein 1 is a ~1.5 mega-Dalton multi-complex of proteins, 
consisting of three homodimers of heavy, intermediate, intermediate light and light 
chains, associated with essential regulatory non-catalytic partners such as dynactin, LIS1 
and Bicaudal D. These partners regulate dynein activity, processivity and cargo binding, 
and their inhibition or depletion can almost completely phenocopy loss of dynein itself 
(Kardon and Vale, 2009; Vallee et al., 2012).  
The heavy chain is dynein’s catalytic core. Each heavy chain polypeptide (> 500 kDa) 
contains a motor domain comprised of a hexameric repeat of AAA domains, a long ~15 
nm antiparallel coiled-coil “stalk” that links the motor to the microtubule binding 
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domain, a short “buttress” antiparallel coiled-coil that supports the base of the stalk and 
contributes to force generation, a “linker” that acts as the main force transducer and 
moves position with the mechanochemical cycle and an unstructured N-terminal tail 
that interacts with the light/intermediate dynein chains, accessory non-catalytic 
partners and cargo (Fig. 3.1; Carter et al. 2011; Kon et al. 2012; Schmidt et al. 2012). 
Biochemical and structural studies have shown that the first AAA domain is the main 
ATP hydrolysis site, with domains AAA2-4 likely exerting regulatory and/or structural 
roles (Kon et al., 2004; Schmidt et al., 2012). It is obvious that substantial allosteric 
communication between the head and microtubule binding domain must occur in order 
to couple the ATP cycle to changes in microtubule affinity, but the details of this process 
are yet to be completely elucidated. Significant improvements in the characterization of 
dynein’s stepping behaviour have been recently described (DeWitt et al. 2012; Qiu et al. 
2012). It was observed that, contrary to most motor proteins, dynein does not undergo 
a “hand-over-hand” movement but, instead, walks in a likely tension-dependent, 















Figure 3.1 Dynein structure and binding partners. (a) Domain structure of dynein heavy 
chain. The color coding is retained in (b). (b) X-ray crystal structure of Dictyostelium 
discoideum dynein heavy chain at 2.8 A resolution (Kon et al, 2012). Note that neither 
the N-terminal tail nor the C-terminal sequences are present. (c) Schematic 
representation of the dynein complex (heavy chains in grey, intermediate chains in 
green, light intermediate chains in darker blue, light chains in lighter blue) and some of 
its binding partners (dynactin in pink, RZZ in yellow).  
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Owing in part to the technical challenges posed by its large size, dynein has been a 
difficult protein to study. Despite recent advances in the structural and biophysical 
characterization of its motor domain and stepping behaviour, dynein remains much less 
well understood than other motor proteins such kinesins (the other main type of 
microtubule-based motor proteins), both in vitro and in cellular contexts. Another 
significant impediment to dynein studies has been the lack of a specific inhibitor that 
could be used acutely at the relevant time-scales needed. Although the ATP analogue 
erythro-9-[3-(2-hydroxynonyl)]adenine and the antioxidant nordihydroguaiaretic acid 
have been previously reported to abrogate dynein function (Bouchard et al., 1981; 
Arasaki et al., 2007), these compounds are non-specific, promiscuous enzyme 
antagonists. As such, their off-target effects cannot be overlooked. Moreover, only one 
specific inhibitor has been described for any other AAA+ family member (Chou et al. 
2011). Therefore, the development of a specific small-molecule inhibitor of dynein 
would provide a significant tool for the advancement of the field and may also aid in the 
development of inhibitors for other types of AAA+ proteins. 
History of the ciliobrevin project 
Dr James Chen’s laboratory at Stanford University uses chemical biology tools to study 
the Hedgehog pathway, a signaling cascade essential for embryogenesis and stem cell 
maintenance (Jiang and Hui, 2008). Hedgehog signaling is intimately related to cilia, 
where components of the pathway are regulated (Goetz and Anderson, 2010). As such, 
dynein activity is essential for proper Hedgehog signaling, as it is involved in the 
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necessary retrograde intraflagellar transport of the Hedgehog signaling complex. 
Accordingly, mouse embryos that are mutant for dynein heavy chain exhibit short and 
few cilia and have altered Hedgehog gene expression (Huangfu and Anderson, 2005). 
One of the hits from a recent cell-based chemical screen for Hedgehog inhibitors in 
the Chen laboratory (Hyman et. Al., 2009), the benzoyl dihydroquinazolinone compound 
“HPI4”, gave indications that it might be a dynein inhibitor: it not only blocked the 
Hedgehog pathway, but it also reduced the number and size of cilia and induced Gli2 
plus-tip accumulation, as seen in the dynein mutants (Kim et al., 2009). Due to its effects 
on cilia, HPI4 was renamed “ciliobrevin”. Dr Chen and Dr Kapoor initiated a 
collaboration to examine whether cilibrevin’s target was in fact dynein and to 
characterize the effects of this small molecule on dynein activity in vitro and during 
mitosis.  
After synthesizing and examining a series of benzoyl dihydroquinazolinone 
analogues with different chlorine substitution patterns and oxidation states, Chen-
laboratory members observed that the derivative lacking a 3-chloro substituent on the 
benzoyl ring system (henceforth “compound 2”) exhibited significantly diminished 
inhibitory activity in Hedgehog signaling and primary cilia formation assays. Compound 
2 was thereafter used as a negative control for in vitro and cell biological assays. The 
analogue with a 7-chloro substitution (henceforth “ciliobrevin D”) exhibited more 
potent inhibitory activity in Hedgehog signaling and cilia formation and was thus used as 




To examine the inhibitory activity of ciliobrevin D on dynein in vitro, colleagues in 
the Kapoor and Chen laboratories carried out microtubule gliding assays with purified 
bovine dynein and showed that ciliobrevin D, but not compound 2, reversibly and 
significantly reduced the average velocity of this motor (Fig. 3.2d, e). Moreover, they 
showed that ciliobrevin D is an ATP-competitive dynein inhibitor (Fig. 3.2f). Specificity 
was shown by the fact that ciliobrevin D has no inhibitory effects on other ATPase motor 
proteins such as kinesins, on other types of AAA+ ATPases such as p97 or Mcm2-7, on 
actin cytoskeleton dynamics or on other signaling pathways such as MAPK and PI3K 
kinase pathways (Fig. 3.2g; Firestone et al. 2012). To begin to examine ciliobrevin 
activity in a cellular context, our colleagues in the Gelfand laboratory (Northwestern 
University) examined the small molecule’s effect on the dynein-dependent melanosome 
aggregation in Xenopus cells upon melatonin stimulation and showed that ciliobrevin D 











Figure 3.2 Characterization of the effects of ciliobrevins in vitro. (a, b) Molecular 
structures of ciliobrevin D (a) and compound 2 (b). (c-g) Figures have been adapted from 
figures 1 and 3 of Firestone et al. 2012. (c) Cilliary effects on NIH3T3 cells after a 24-hour 
incubation in a 30 µM dose of compound 2, ciliobrevin D or an equivalent amount of 
DMSO. Staining for DNA (DAPI; blue) and the cilium protein ARL13b (green) is shown. (d-
g) Effects of ciliobrevins on recombinant or purified bovine dynein in vitro. (d) 
Kymographs of fluorescently labeled microtubules sliding on coverslip-adhered purified 
bovine dynein in the presence of 100 µM of ciliobrevin compounds are shown. (e) 
Quantification of data from (d). Average from at least 56 microtubules ± s.e.m. shown. 
Asterisk indicates P < 10-6. (f) Hanes–Woolf plot of recombinant rat dynein motor in the 
presence of increasing concentrations of ciliobrevin D. (g) Effects of increasing 
concentrations of ciliobrevin D, compound 2 or DMSO on the ATPase activities of 
recombinant motor domains of rat cytoplasmic dynein, human kinesin-1 and human 












With my colleagues having shown that ciliobrevin D is a specific and reversible 
inhibitor of dynein activity both in vitro and in interphase cells, my contribution to the 
project was to validate the small molecule’s effects in mitotic cells by examining 
whether the phenotypes created agreed with phenotypes seen for other types of dynein 
mitotic inhibition. An expectation was that ciliobrevin might also be a useful tool for the 
study of the roles of dynein in checkpoint silencing and how dynein relates to other 
silencing-related proteins such as the Mad2-inhibitor p31/Comet. For instance, we could 
examine whether dynein inhibition enhances the Mis12-Mad1 checkpoint arrest or the 
requirement for p31/Comet in checkpoint silencing, or whether p31/Comet- and 
dynein-dependent silencing mechanisms are additive, synergistic, or redundant. 
Dynein in mitosis 
In mitosis, cytoplasmic dynein 1 (hereafter, dynein) localizes at kinetochores, at spindle 
poles and at the cell cortex and has functions in spindle assembly, spindle positioning, 
the regulation of kinetochore-microtubule interactions and the spindle assembly 
checkpoint.  
Dynein interacts with and transports the cross-linking protein NuMA towards the 
microtubule minus ends. Hence, dynein has a crucial role in the spindle pole formation 
and organization, gamma-tubulin recruitment and thus in the establishment of spindle 
bipolarity (Merdes et al., 2000; Young et al., 2000). By acting on the cortical 
microtubules that emanate towards the cortex of the cell, dynein also plays a role in 
positioning the spindle within the cytoplasm (Moore et al., 2009; Grill and Hyman, 2005; 
75 
 
Kiyomitsu and Cheeseman, 2012). Dynein is also present at unattached kinetochores, to 
which it is recruited via the interaction of its non-catalytic partner p50 (a component of 
dynactin) with the RZZ complex component ZW10 (Starr et al., 1998). There, dynein has 
been proposed to participate in microtubule end-on attachment and to regulate the 
stability of kinetochore-microtubule interactions and kinetochore orientation (Varma et 
al., 2008). Dynein also removes checkpoint proteins such as Mad1 and Mad2 from 
bioriented kinetochores and transports them towards the spindle poles. This “dynein 
stripping” process is believed to contribute to checkpoint silencing and anaphase 
progression (Howell et al., 2001; see introduction for further details). Checkpoint 
silencing remains the least well understood step of checkpoint signaling; novel 
molecular tools for its study would therefore have a big impact on the field. 
These and other presumed mitotic functions of dynein have been described and 
studied using cell-biological techniques such as the microinjection of antibodies, the 
overexpression of dominant-negative binding partners or heavy-chain truncations, or 
heavy chain RNA interference. These perturbations are crude, as their specificity, 
acuteness and reversibility are sub-optimal. In fact, significant inconsistency and 
controversy have arisen from the use of different techniques (Bader and Vaughan, 
2010). It is thus that a specific, acute, reversible molecular tool such as a small-molecule 
inhibitor would be useful for the reliable characterization of dynein’s functions during 
mitosis. 
In the next section, I characterize the effects of ciliobrevin D in mitosis. I show that, 
in agreement with previously reported dynein functions, ciliobrevin D reversibly inhibits 
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spindle assembly, spindle pole organization and focusing, as well as stable kinetochore-
microtubule interactions.  
Results 
Ciliobrevin disrupts spindle bipolarity in mammalian cells 
As described above, dynein acts with the cross-linking protein NuMA to focus the minus 
ends of microtubules and help establish the spindle poles. Inhibition of dynein activity 
with anti-dynactin antibodies or the expression of dominant negative constructs thus 
results in unfocused poles (Merdes et al., 2000; Gaetz and Kapoor, 2004).  To determine 
whether ciliobrevin D could recapitulate these phenotypes, I treated a metaphase-
enriched population of NIH-3T3 cells with 50 µM of ciliobrevin D or the inactive 
analogue (compound 2) for one hour and examined their mitotic structures by 
immunofluorescence microscopy.  Treated cells exhibited abnormal (unfocused, 
multipolar, or collapsed) mitotic spindles with disrupted gamma tubulin localization (Fig. 
3.3a, d-f). Cells incubated with the non-cilia-disrupting analogue or vehicle alone 
(DMSO) exhibited normal spindle morphologies (Fig. 3.3b-c).  Similar ciliobrevin-induced 











Figure 3.3 Ciliobrevin D disrupts spindle bipolarity and spindle pole organization.  (a-g) 
NIH3T3 (a-f) or HeLa (g) cells were incubated with 10 µM proteosome inhibitor MG132 
for 90 min and subsequently cultured in a medium with both MG132 (10 µM) and either 
an inactive ciliobrevin analogue (compound 2) (c) or ciliobrevin D (d-f) at a 50 µM dose 
or an equivalent amount of DMSO (a), for 1 hour. Cells were fixed and stained for DNA, 
α-tubulin, and γ-tubulin and the morphology of their spindles were scored as bipolar or 
abnormal (multipolar, collapsed or unfocused) (a, g) n= 3 independent experiments, > 
150 spindles counted for each condition. (b-f) Representative images of NIH3T3 treated 
as above.  (h) Dose-response curve for NIH-3T3, HeLa and RPE-1 cells exposed to 
increasing concentrations of ciliobrevin D. For each concentration, cells were treated, 

















Dynein is also required for establishing stable kinetochore-microtubule attachments 
(Varma et al., 2008).  Accordingly, ciliobrevin D treatment disrupted the formation of 
cold-stable microtubules (as explained in the previous Chapter, an indicator of proper 










Figure 3.4 Ciliobrevin D disrupts proper cold-stable kinetochore-microtubule 
interactions. (a-d) NIH-3T3 (a-d) or HeLa (d) cells were incubated with 10 µM 
proteosome inhibitor MG132 for 90 min and subsequently cultured in a medium with 
both MG132 (10 µM) and either an inactive ciliobrevin analogue (compound 2) (b) or 
ciliobrevin D (c) at a 50 µM dose or an equivalent amount of DMSO (a) for 1 hour before 
being incubated on ice for 10 min. Cells were then fixed and stained for DNA, α-tubulin, 
γ-tubulin and the kinetochore marker CREST. Individual channels and an overlay of 
CREST and α-tubulin are shown. Insets (selected optical sections) show individual cold-
stable microtubule-attached (a, b) or unattached kinetochores (c) (4-fold magnification). 
(d) Quantification of the effects of DMSO, compound 2 or ciliobrevin D on NIH3T3 and 











Ciliobrevin does not affect dynein localization 
To investigate if these spindle-disruptive effects were associated with altered 
localization of dynein, I examined the targeting of key binding partners that recruit or 
co-localize with this motor at different intracellular sites.  p150Glued is the main 
component of the dynein essential non-catalytic partner dynactin, and it tightly 
interacts with dynein’s intermediate chain throughout mitosis (Holzbaur et al., 1991; 
Kardon and Vale, 2009). Dynactin recruits dynein to kinetochores and spindle poles 
during mitosis; moreover,  disruption of p150Glued function mimics loss of dynein activity 
(Starr et al., 1998; King et al., 2003; Schroer, 2004). Therefore, I analyzed the subcellular 
localization of p150Glued in the presence of ciliobrevin D.  Immunofluorescence analysis 
showed that p150Glued localized to the disorganized spindle poles of metaphase-







Figure 3.5 Ciliobrevin D does not affect the localization of p150Glued at spindle poles. 
(a-e) NIH-3T3 cells were incubated with 10 µM proteosome inhibitor MG132 for 90 min 
and subsequently cultured in a medium with both MG132 (10 µM) and either or 
ciliobrevin D (b-e) at a 50 µM dose or an equivalent amount of DMSO (a). Cells were 
then fixed and stained for DNA, α-tubulin, and p150Glued. Individual channels and an 
overlay of CREST and α-tubulin are shown. Scale bar, 5 µm.  
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I then analyzed the targeting of p150Glued to kinetochores.  Because kinetochore 
recruitment of p150Glued and dynein depends on microtubule-attachment status, I 
treated the cells with the microtubule poison nocodazole, to be able to disregard effects 
due to differences in attachment.  To ensure that ciliobrevin treatment does not disrupt 
outer kinetochore structure, I also analyzed the localization of two outer kinetochore 
proteins under the same conditions. These proteins were ZW10 (the component of the 
RZZ complex that recruits dynein to kinetochores by interacting with the dynactin 
component p50; Starr et al., 1998), and the kinetochore-associated kinesin-like protein 
Centromere protein E (CENP-E; Yen et al., 1991).  Quantitative analysis showed that 
p150Glued, ZW10, and CENP-E were localized to outer kinetochores at comparable levels 
to control cells, indicating that recruitment of these proteins and kinetochore structure 
itself are not disrupted by the ciliobrevins (Fig. 3.6). These results suggest that dynein is 
properly recruited to kinetochores and spindle poles in ciliobrevin-treated cells and that 








Figure 3.6 Quantitative analysis of ciliobrevin effects on protein localization at 
unattached kinetochores. (a-f) NIH-3T3 cells were treated with the designated 
compounds (at 50 µM) or an equivalent amount of DMSO for 45 min before addition of 
1 μg/mL nocodazole (and either ciliobrevins or DMSO) for another 45 min. The cells 
were then fixed and stained with CREST, p150Glued, and either ZW10 (b, d) or CENP-E (c, 
e).  Fluorescence intensities at individual kinetochores were quantified. Data shown 
here represent the intensity distributions of 2-4 independent experiments, with each 
experiment involving the analysis of 4-7 cells and 10-15 kinetochores per cell per 
condition (120-390 kinetochores per condition). (a-c) Histograms show the distribution 
of signal intensities of p150Glued (a), ZW10 (b), and CENP-E (c) in cells treated as above. 
(d,e) Representative images of cells treated and quantified as described above. 
Numbers associated with individual micrographs represent the average 
immunofluorescence intensity of the respective protein at the analyzed kinetochores in 
each image, relative to the overall average signal observed in DMSO-treated cells. Scale 


















Ciliobrevin’s effects are reversible and its use reveals dynein’s role in the 
maintenance of bipolarity 
To further characterize the mitotic defects associated with ciliobrevin treatment, I 
established a GFP-tubulin-expressing NIH-3T3 stable cell line and used it for real-time 
confocal microscopy (Fig. 3.7 and 3.8).  Severe defects were observed within minutes of 
ciliobrevin D treatment: spindles appeared collapsed, bipolarity was lost, spindle poles 
appeared disorganized and cells arrested in mitosis (Fig. 3.7b).  Upon relief of inhibition, 
bipolar spindles rapidly re-emerged and chromosomes were segregated at anaphase 
(Fig. 3.7c-d). Interestingly, upon ciliobrevin D wash-out, a minority of cells (~5%) went 
through a transient multipolar stage, after which the supernumerary poles were 
coalesced and bipolarity was recovered, in accordance with dynein’s roles in pole 
focusing (Fig. 3.7d). No pronounced defects in chromosome segregation were apparent 














Figure 3.7 Ciliobrevin D’s effects on mitotic spindles are fast and reversible. (a-d) The 
media of asynchronous populations of NIH-3T3 cells stably expressing GFP-tubulin were 
exchanged for medium containing Ciliobrevin D or DMSO. Prophase cells were identified 
and time-lapse images were acquired. (a, b) Representative images of cells after the 
addition of 50 μM ciliobrevin D (b) or an equivalent amount of DMSO (a). (c, d) 
Representative images of the cells after the addition of 50 μM ciliobrevin D followed by 
removal of the compound (“wash-out”). Examples show the recovery of bipolar spindle 
morphology, which may involve pole re-focusing of supernumerary poles (d, arrows). 
Times (min) relative to compound addition (a, b), or compound wash-out (c, d) are 
shown. Scale bar, 5 μm. 
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I next examined the effects of ciliobrevin exposure on pre-formed spindles of 
metaphase-arrested cells.  Again, I observed several defects in spindle size and shape 
and pole fragmentation within minutes of ciliobrevin D addition (Fig. 3.8a-d).  The live-
cell recordings also suggested that ciliobrevin D treatment caused a four-fold reduction 
in overall microtubule levels in dividing cells (Fig. 3.8e). Although the inactive compound 
2 also caused a two-fold reduction of tubulin fluorescence, spindle defects were not 
observed. Importantly, I found that microtubule levels in non-dividing cells were 
unaffected by inhibitor treatment (Fig. 3.8f-g), indicating that the ciliobrevins are not 
tubulin poisons and that these effects are mitosis-specific. I then examined the recovery 
of these disrupted spindles after ciliobrevin removal.  Within minutes after wash-out, 
microtubule levels recovered and supernumerary poles in multipolar spindles coalesced 
to re-establish bipolarity (Fig. 3.8c-d), highlighting dynein’s role in pole focusing. 
Together these data are consistent with ciliobrevin D inhibiting dynein’s functions in 
pole organization and focusing. Because these spindle-disrupting effects are seen in cells 
that were already bipolar at the start of the experiment, these data reveal a hitherto 
under-appreciated requirement for dynein activity in the maintenance of spindle 






Figure 3.8 Ciliobrevin D’s effects on metaphase-arrested and interphase cells. (a-e) 
NIH-3T3 cells stably expressing GFP-tubulin were arrested in metaphase with MG132 
(10 μM) and subsequently treated with DMSO (a) or 30 μM of either compound 2 (b) or 
ciliobrevin D (c, d). The compounds were later washed out at the indicated time. Time-
lapse images were acquired at the indicated times (min relative to the initial MG132 
treatment). Representative examples of ciliobrevin D-treated cells show recovery of the 
spindle into a bipolar morphology after severe pole disruption (c) or severe microtubule 
depolymerization (d). (e) Quantification of GFP-tubulin intensities of images 
corresponding to the indicated times, relative to the initial intensity for each condition. 
Average of 2-3 cells is shown. (f, g) Ciliobrevin D does not disrupt the interphase 
microtubule network. NIH-3T3 cells stably expressing GFP-tubulin that were in 
interphase were incubated in 30 μM ciliobrevin D or an equivalent amount of DMSO for 
30 min before the compounds were washed out. Post-wash-out images were acquired 
after 15 min and compared to images acquired 15 min before wash-in. (f) Histogram 
depicting the ratio of microtubule intensities after and before washout of the relevant 
compound, as gauged by GFP intensity (n= 2 independent experiments, >10 cells per 
condition). Average ± s.e.m. shown (g) Representative images of the cells quantified 
above and their individual pre-washout/post-washout ratios.  Scale bars, (a-d) 5 μm; (g) 







Conclusions and discussion 
In this Chapter, I examined the effects of ciliobrevin D on mitotic cells, in a collaborative 
effort to characterize this molecule as the first specific small-molecule inhibitor of the 
motor protein dynein. I showed that, as expected from previously published studies of 
dynein inhibition with cruder molecular biology tools, ciliobrevin D reversibly causes a 
severe disruption to pre-formed spindles, precludes de novo spindle assembly and 
disrupts proper kinetochore-microtubule interactions in human and murine cells. The 
use of ciliobrevin D on metaphase-arrested cells revealed that dynein is involved not 
only on spindle bipolarity formation, but also in its maintenance. The data shown here, 
together with the work of collaborators in the Kapoor, Gelfand, O’Donnell and Chen 
laboratories, validate ciliobrevin D as the first specific, reversible, ATP-competitive 
small-molecule antagonist of the AAA+ ATPase minus-end-directed motor protein 
dynein (Firestone et al. 2012). 
My work also reveals the limitations of ciliobrevin D in mitotic research: because it 
inhibits both pole- and kinetochore-localized dynein, causing severe spindle disruption 
and thus activating the spindle assembly checkpoint, its use in checkpoint silencing 
studies is precluded. In order to be able to use a dynein inhibitor for such studies, the 
molecule would need to inhibit the kinetochore-localized dynein only (i.e. not the 
dynein molecules at the poles). Further chemical derivation and structure-activity-
relationship studies could feasibly lead to the discovery of dynein isoform-selective 
ciliobrevins (i.e. to distinguish cytoplasmic dynein 1 from 2). However, given that both 
kinetochore- and pole-associated cytoplasmic dynein are both type 1, the generation of 
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a kinetochore-specific ciliobrevin will likely be extremely challenging, if at all possible. 
This is because, although we do not yet know what the binding site for ciliobrevin D on 
dynein’s motor domain is, the fact that it is ATP-competitive suggests it is likely to bind 
at or near the active site—which is the same for all cytoplasmic dynein 1 molecules, 
regardless of their intracellular localization. Nevertheless, it is possible that the binding 
to different recruiting partners that leads to dynein’s differential localization is 
regulated by post-translational modifications on dynein’s polypeptides. If so, and if 
those modifications induced structural changes to the ciliobrevin binding site, it may be 
possible to discover kinetochore-specific dynein 1 ciliobrevin inhibitors. However, this 
remains, in my opinion, unlikely. A more feasible approach might be to screen for 
molecules that abrogate dynein’s interaction with the kinetochore recruiting factor, i.e. 
molecules that disturb the p50–ZW10 interaction, in analogous fashion to previously 
used dominant-negative strategies. However, shortcomings would include the need to 
undertake an entirely new chemical screen and to overcome the challenges involved in 
using small molecules to impede protein-protein interaction (Arkin and Wells, 2004). 
 Notwithstanding this limitation for checkpoint silencing studies, the ciliobrevin 
compounds represent an important new, specific tool for biochemical, biophysical, 
structural, cellular and clinical studies of dynein and its associated processes. For 
instance, ciliobrevins may be used to dissect the recently described relationship 
between cilia and cell cycle progression at the G1/S transition (Li et al. 2011; Kim et al. 
2011). Supporting this, anecdotal evidence from my own and my colleagues’ studies 
with ciliobrevin D suggests the molecule inhibits mitotic entry (data not shown). 
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Furthermore, given that ciliobrevins are the first class of Hedgehog signaling inhibitors 
downstream of Smoothened, they are significant additional tools for Hedgehog research 
and may also have clinical applications (in particular, ciliobrevins 7 and 8—not described 
here—which affect cilia formation without inhibiting dynein activity, Firestone et al. 
2012). Ciliobrevin D and derivatives may also be used in in vitro and crystallographic 
studies to dissect the heretofore elusive details of dynein’s mechanochemical cycle. 
What is more, ciliobrevin D will likely be useful in a variety of cellular studies of 
interphase cells, such as research on Golgi architecture, endosome recycling, axonal 
transport, neurodegeneration, as well as mRNA localization during embryonic 
patterning. Lastly, ciliobrevins may also provide a privileged starting point for the 
development of specific antagonists of the variety of other AAA+ family members, which 
includes not only biologically interesting proteins, but also clinically relevant targets 
such as the peroxisome proteins Pex1 and Pex6, hereditary spastic paraplegia-inducing 





Chapter 4: Discussion and future 
directions 
Summary 
In the previous Chapters, I examined different mechanisms that contribute to mitotic 
regulation. In Chapter 2, I examined the effect of constitutive Mad1 localization to 
different parts of the chromosome. Using a fusion protein of Mad1 and the kinetochore 
protein Mis12, I showed that constitutive Mad1 localization at the kinetochore leads to 
constitutive checkpoint arrest even after all chromosomes have bioriented. This finding 
indicated that the localization of Mad1-Mad2 at the kinetochore is sufficient for the 
establishment of checkpoint arrest. I also showed that ectopic localization of Mad1-
Mad2 to the chromosome “arm” by fusion of Mad1 to H2B, or to the centromere by 
fusion of Mad1 to CENP-E, was not able to evoke checkpoint arrest, lending some 
support to the notion that kinetochores are essential for checkpoint signaling. Being 
able to uncouple checkpoint signaling from chromosome biorientation using the Mis12-
Mad1 fusion, I then showed that BubR1, Mps1 and Aurora B activities (but not those of 
Polo) are necessary for the maintenance of checkpoint arrest, independently of the 
status of chromosome biorientation. In Chapter 3, I examined the mitotic effects of 
ciliobrevin D, work that contributed to the validation of the molecule as the first specific 
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small-molecule inhibitor of the motor protein dynein. I showed that dynein inhibition by 
ciliobrevin D not only recapitulates previously reported mitotic roles of dynein, but also 
reveals a new function for this motor protein in the maintenance of spindle bipolarity. I 
also explained why the molecule is not useful for further examination of the roles of 
dynein in the metaphase-to-anaphase transition. In this Chapter, I discuss further 
implications of these results, as well as possible directions in which these results can be 
taken to extend our knowledge of mitosis.  
Future directions 
The role of kinetochores in checkpoint signaling  
In Chapter 2, I showed that constitutive Mad1 localization at kinetochores is sufficient to 
induce checkpoint arrest, even if all chromosomes are bioriented. Following this, I 
wanted to examine whether constitutive localization of Mad1 on other parts of the 
chromosome would lead to the same result. Several lines of evidence suggest that 
checkpoint activity can originate in the cytoplasm, suggesting that kinetochores are not 
essential for checkpoint signaling (Windecker et al., 2009; Meraldi et al., 2004a). 
Therefore, I reasoned that ectopic localization experiments should allow examination of 
the role of kinetochores and determine whether they are necessary for checkpoint 
signaling. 
Contrary to that seen with the Mis12-Mad1 fusion protein, fusion of Mad1 to 
neither H2B nor CENP-B led to checkpoint arrest. I took these data to support the notion 
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that kinetochores are essential for checkpoint signaling. However, several questions 
were left unanswered. Firstly, the fact that ectopic localization with those fusion 
partners and with those specific linkers used did not result in checkpoint arrest does not 
mean that all possible ectopic localization experiments would give the same result. In 
other words, the negative results may have been due to the wrong choice of partners 
or, more simply, to technical issues. Secondly, although I showed that H2B-Mad1 
recruits Mad2 all along the chromosome, I did not examine whether that ectopically 
recruited C-Mad2 was able to recruit and activate cytoplasmic O-Mad2 with rates 
comparable to control values of Mad2 activation at the kinetochore. For instance, it is 
possible that technical issues such as the length of the linker precluded Mad1-bound-C-
Mad2 from catalytically amplifying O-Mad2 molecules in the cytoplasm, even though it 
correctly bound Mad1 on the chromosome. This issue could be addressed with FRAP 
experiments to examine Mad2’s dynamics, as has been done in vitro and for Mad2 at 
the kinetochore (Howell et al., 2000; Shah et al., 2004; Howell et al., 2004; Vink et al., 
2006). Even with these control experiments, the notion that kinetochores are essential 
for checkpoint signaling would remain underdetermined, as a specific configuration may 
exist in which ectopic recruitment of Mad1-Mad2 may elicit checkpoint arrest. Different 
strategies for ectopic localization may therefore prove more useful.  
Alternatively, reduced kinetics for Mad2 activation at the chromosome arm may 
indicate not a mere technical deficiency, but the fact that additional factors are needed 
in the vicinity of the core tetramer to make O-Mad2 amenable for activation. For 
instance, it has been shown that Mps1 activity is needed for the sustained recruitment 
98 
 
of O-Mad2 to the kinetochore, and it has been speculated that this may be required to 
antagonize cytoplasmic Mad2’s interactions with its inhibitor p31 (Hewitt et al., 2010). 
This hypothesis could be tested by depleting p31/Comet in cells expressing H2B-Mad1 
and observing whether checkpoint arrest can be established in that case. Additionally, 
an ectopic recruitment strategy that not only mislocalizes Mad1-Mad2, but also 
ectopically recruits other checkpoint pathway components close to the core tetramer 
may also shed light on these issues. Such a strategy is further discussed in following 
section and in the Appendix chapter. 
Conditional recruitment of Mad1 to kinetochores or other chromosomal locations 
The use of a Mis12 fusion to constitutively localize Mad1 at kinetochores was a 
successful method to show that kinetochore Mad1 localization is sufficient to induce 
checkpoint arrest independently of biorientation. A modification that would make this 
approach useful for the examination of a variety of mitotic questions would be to make 
Mad1’s interaction with Mis12—and, hence, Mad1-Mad2’s localization at kinetochores 
and checkpoint arrest— not constitutive but conditional. 
 A system that synchronized cells at metaphase without the need for chemical 
inhibitors with questionable off-target and secondary effects (e.g. the use of the 
proteosome inhibitor MG132), or for the inhibition of other key mitotic enzymes, would 
be a useful research tool for the study of post-anaphase processes. The conditional 
recruitment and release of Mad1 to and from kinetochores might allow us to reliably 
synchronize cells by arresting in them metaphase (owing to Mad1 kinetochore 
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localization) and releasing into anaphase upon the removal of Mad1. This approach 
makes the assumption that the release of the engineered Mad1-Mad2 from the 
bioriented kinetochores would be sufficient to induce checkpoint silencing, analogously 
to what happens in normal cells with dynein stripping— it must be noted, however, that 
the importance of this mechanism is debatable. This uncertainty notwithstanding, such 
a conditional system would not only be useful as a synchronization tool, but may also be 
useful in studies of the inter-relationships between the different checkpoint silencing 
mechanisms.  
A conditional Mad1-recruitment system may be achieved by combining the idea of 
the Mis12-Mad1 fusion with the rapamycin-dependent dimerization of FRB and FKBP 
(Banaszynski et al., 2005). For instance, we could use a mCherry-Mis12-FRB and FKBP-
GFP-Mad1 combination to recruit Mad1 to kinetochores in a conditional fashion. The 
components would need to be tested for localization, dimerization and release 
depending on rapamycin presence, kinetics, non-alteration of kinetochore-microtubule 
interactions, etc. A potential technical pitfall is that rapamycin wash-out is difficult to 
achieve in cells. An alternative strategy may be to use a chemical biological system that 
controls not protein localization, but stability. By fusing Mis12-Mad1 to the protein 
FKBP(L106P, hereafter FKBP*), we could control stability of the protein (and, hence, the 
establishment of and release from checkpoint arrest) with the small molecule Shield: 
FKBP* acts as a degradation tag on its own, but its proteolysis is prevented in the 
presence of this compound (Banaszynski et al., 2006). The FKBP*/Shield system has 
been successfully used to control protein expression in vertebrate and insect cells, as 
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well as in whole organisms, but it has not so far been used specifically in mitotic cells 
(Armstrong and Goldberg, 2007; Herm-Gotz et al., 2007; Banaszynski et al., 2008). 
Before using this approach, we would need to validate its use during mitosis. For further 
explanation and discussion of these strategies, as well as for preliminary results, please 
refer to the Appendix chapter. 
The control of checkpoint arrest establishment and release independently of 
chromosome biorientation need not be limited to manipulations of Mad1. It has 
recently been shown that, the MCC being the most downstream effector of checkpoint 
signaling, expression of a fusion of Mad2 and BubR1 (or of Mad2 and BubR1 that are 
artificially dimerizable via leucine zippers) is sufficient to induce checkpoint arrest in 
budding yeast (Lau and Murray, 2012). Expressing FRB-FKBP-dimerizable or 
FKBP*/Shield-regulated versions of these proteins in human cells might be an 
alternative mechanism for cell synchronization and the examination of post-anaphase 
events. Given that these are the most downstream components of the systems, the 
kinetics of onset and release might be faster than those achieved by the regulation of 
Mad1 localization or stability. This strategy, of course, remains to be experimentally 
tested. 
Finally, it may be worth revisiting the question of whether it is possible to establish 
checkpoint arrest from a non-kinetochore location. Achieving it would not only show 
that kinetochores are not essential for the checkpoint, but it would also allow us to 
tackle other fundamental questions about the SAC signaling pathway. For instance, it 
would inform us on what the minimal components of the checkpoint are, which may 
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lead to improved in vitro reconstitution assays and analyses. Moreover, if we knew how 
to reconstitute checkpoint arrest from defined ectopic location, we would be able to 
carry out quantitative studies of how the checkpoint stop-anaphase signal is amplified 
from a single locus (analogously to signaling from a single non-bioriented kinetochore). 
A system that might be amenable for this may be the lac–ISceI–tet cell line, which 
contains a single stable integration of an array of lac operators, followed by an array of 
tet operators (Soutoglou et al., 2007). This method would involve recruiting pairs of 
checkpoint proteins (e.g. Mad1 and a kinase) fused to lacI or TetR respectively and 
examining whether that recruitment could evoke checkpoint arrest (and release). This 
method is further explained in the Appendix chapter. Similarly to the H2B and CENP-B 
fusions described above, negative results will not necessarily indicate that the system is 
not useful and that kinetochores are necessary for checkpoint signaling. 
The role of kinase activity in checkpoint maintenance and silencing 
In Chapter 2, I showed that Aurora B or Mps inhibition via small molecules is sufficient 
to override the arrest caused by the expression of Mis12-Mad1. This indicates that 
Aurora B and Mps1 activities are needed for the maintenance of checkpoint arrest, 
independently of their roles in kinetochore assembly and checkpoint protein 
recruitment. How does kinase inhibition elicit entry into anaphase? Kinases are opposed 
by phosphatases. In the absence of sustained kinase activity, phosphatase activity tips 
the equilibrium towards dephosphorylation of substrates. More importantly, what are 
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the relevant Aurora and Mps1 substrates and sites? How are the kinase circuits inter-
related? What are the relevant opposing phosphatase complexes?  
Feasible kinase substrate candidates downstream of kinetochore recruitment are 
the members of the MCC, the APC/C-cdc20 complex and other silencing players, such as 
p31/Comet and dynein. In fact, a few phosphorylation events on MCC components have 
been identified in different organisms. For instance, phosphorylation of Mad2 by Mps1, 
of BubR1 by Aurora and of cdc20 by Bub1 have been shown to affect checkpoint arrest 
and release (Tang et al., 2004; King et al., 2007; Shepperd et al. 2012). Interestingly, 
both positive and negative effects on checkpoint arrest have been observed (Shepperd 
et al. 2012). These results should be re-valued and evaluated in more detail in the light 
of the updated models of direct kinase roles in checkpoint signaling.  
Furthermore, my results that inhibition of either kinase is sufficient to override the 
checkpoint are in line with evidence that Aurora B and Mps1 act in a common pathway 
(Jelluma et al. 2010; Lan and Cleveland, 2010). Nevertheless, the fact this sufficient 
inhibition occurs after biorientation has been achieved and Mps1 has been released to 
the cytoplasm suggests that a more complex pathway may be in place. It is also very 
likely that the checkpoint silencing circuit will include different types of motifs and 
feedback loops. Therefore, it is paramount that the whole set of players and interactions 
be identified. Identification of kinase/phosphatase substrates could be done, for 
instance, using a combination of bioinformatics, chemical genetics, mass spectrometry 
and high-throughput RNAi screens, to be later validated in cell biological experiments 
103 
 
(e.g. Hegemann et al. 2011; Hengeveld et al. 2012; Oppermann et al. 2012). Our Mis12-
Mad1 construct may be of use in such screens and validation assays. 
It will also be interesting to examine how the kinase/phosphatase circuits interact 
with the other mechanisms of checkpoint silencing and what their relative contributions 
are in a variety of different model organisms. For instance, does PP1 dephosphorylation 
affect dynein stripping in higher eukaryotes? Could PP1-gamma be responsible for 
activating p31/Comet? The fact that Aurora B or Mps1 inhibition is sufficient to override 
checkpoint arrest in human cells suggests that they might be the most important 
components of the system. Furthermore, the fact that Mad1-Mad2 remain at the 
kinetochores of the segregating chromosomes supports the idea that dynein stripping 
might play a merely accessory role in checkpoint silencing (this work and also Canman et 
al., 2002). This is also in line with the fact that dynein is not necessary for mitosis of 
lower eukaryotes.  A dynein small molecule inhibitor that acted only at kinetochores 
would have been a very useful tool to examine these questions in more detail. 
Unfortunately, as discussed in Chapter 3, ciliobrevin D is not useful for these types of 
experiments, as its inhibition of pole-localized dynein leads to the disruption of bipolar 
spindles and the maintenance of checkpoint arrest. The development of a small 
molecule that inhibited the interactions between dynein and ZW10 would be useful tool 
in this regard. 
Finally, could a better understanding of checkpoint silencing lead to the 
development of better therapeutic strategies in cellular hyper-proliferative diseases 
such as cancer? Preventing checkpoint silencing not only delays proliferation, but also 
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increases the probabilities of death in mitosis (Janssen and Medema, 2011). As such, it 
could provide alternative strategies and uncover new combination therapies that might 
be effective. 
Perspective  
The field has come a long way since the initial identification of the first checkpoint 
components in 1991 (Hoyt et al., 1991; Li and Murray, 1991). Nevertheless, several 
unanswered question still remain. For instance, what is the precise architecture of the 
kinetochore, before and after attachment? Although significant structural advances 
have been made recently, we still do not fully grasp how the interactions between the 
kinetochore and checkpoint components change upon biorientation. Are kinetochores 
really essential for checkpoint activity per se, or is their role actually to couple 
biorientation with silencing? Similarly, how does the structural change upon 
biorientation translate into checkpoint silencing, especially in the cytoplasm? And what 
do the details of checkpoint silencing differ in different organisms? Is silencing 
complexity correlated with the rise of complexity in kinetochore structure, attachment 
modes, and centromere specification?  
Another important advance has been the recognition that checkpoint kinases do 
indeed have a direct role in checkpoint signaling, and we are beginning to uncover how 
their phosphorylations prevent cdc20 activity. Nevertheless, as mentioned above, 
crucial details such as specific kinase substrates and their relevant sites, the possible 
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inter-plays of different kinase loops and the relevant phosphatase regulation are still 
unknown.  
Moreover, unresolved issues still remain with the Mad2-template model. What is 
the definitive answer on the question of C-Mad2 auto-catalytic amplification in the 
cytoplasm? What is p31/Comet’s physiological contribution as a “brake”? How are 
Mad1-C-Mad2 complexes in the cytoplasm regulated? How does SAC activity originate 
in the cytoplasm independently of kinetochores, and is this a physiologically important 
process, or is it just a minor component? Likewise, we need a much clearer 
understanding of the amplification parameters and kinetics in cells and a more careful 
examination of the notion that a single non-bioriented chromosome can establish as 
robust an arrest as the full set of unattached kinetochores in metaphase. 
Contributions of this thesis 
In this thesis, I have contributed to the study of some fundamental questions of the 
spindle assembly checkpoint mechanism. Is Mad1-Mad2 kinetochore localization 
sufficient for checkpoint arrest? Is kinase activity necessary for checkpoint signaling per 
se? Can we develop chemical tools for the study of checkpoint silencing? I have arrived 
at some answers, but, invariably, more questions remain. Are kinetochores necessary 
for checkpoint signaling? What are the kinase substrates relevant for checkpoint signal 
maintenance? What is the circuit for checkpoint silencing?  
Clearly, much more cellular, biochemical, structural and biophysical research 
remains to be done in these and other areas to achieve a complete description of the 
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complex workings of the spindle assembly checkpoint. I hope the findings and tools 




Appendix: Towards a system for 
conditional checkpoint signaling 
independently of chromosome 
biorientation 
Summary  
In the previous Chapters, I showed how constitutively kinetochore-localized Mad1 is 
sufficient to induce spindle assembly checkpoint signaling independently of 
chromosome biorientation. I discussed how it would be beneficial to have a conditional 
system for Mad1 recruitment to the kinetochore or elsewhere on the chromosome that 
would allow us not only to reliably synchronize and release cells at the metaphase-to-
anaphase transition, but also to investigate, among others, questions regarding the 
need for kinetochores as signaling hubs, the minimal components sufficient for 
checkpoint signaling and the mechanism of checkpoint signaling amplification. In this 
Chapter, I describe preliminary efforts towards the development of such a system. 
Firstly, I describe attempts to use a rapamycin-dependent dimerizer system of the 
domains FRB and FKBP fused to Mis12 and Mad1, respectively. This approach proved 
unsuccessful due to inappropriate expression levels of the fusion proteins involved. 
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Secondly, I describe a related approach consisting on Shield-dependent rescue of an 
FKBP(L106P)-Mis12-Mad1 fusion protein (hereafter, FKBP*-Mis12-Mad1). I was able to 
validate the use of this approach in mitotic cells, and preliminary results indicate that 
Shield-rescued FKBP*-Mis12-Mad1 does indeed induce metaphase arrest. Lastly, I 
describe a system to conditionally recruit checkpoint components to ectopic locations 
on the chromosome arm, by interaction of lac and tet repressors to their respective 
DNA operators. This system, although promising, is still in the cloning stage. The full 
development of these of other systems for a rapid, reversible and tunable induction of 
checkpoint signaling independently of chromosome biorientation would be a significant 
tool for the dissection of long-standing mitotic questions. 
Conditional checkpoint signaling independently of chromosome biorientation 
Rapamycin-dependent FRB-FKBP-mediated Mis12-Mad1 dimerization 
The localization of Mad1 at the kinetochore is sufficient to induce checkpoint arrest 
even when chromosomes are bioriented. I reasoned that if I could conditionally and 
reversibly recruit Mad1 to kinetochores by an artificial heterodimerization method, I 
may be able to conditionally establish and release a checkpoint-based metaphase arrest 
independently of the checkpoint’s primary signal, i.e., I would have a reliable system for 
arresting and releasing cells at the experimenter’s convenience, without the need for 
inhibition of kinases or other mitotic proteins that might be under study. 
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The first approach I took towards this was using a rapamycin-dependent FRB-FKBP 
dimerization system. Rapamycin is a 31-membered macrolide small molecule that has 
been of use in molecular biological studies due to its ability to simultaneously bind with 
high affinity to the FRB domain of mTOR and to the protein FKBP, thereby inducing their 
heterodimerization (Banaszynski et al., 2005). This feature has been exploited as a 
research tool to heterodimerize proteins by fusing them to FRB and FKBP and it has 
proven a successful strategy to control the spatio-temporal activation of a variety of 
proteins. Moreover, the system has been successfully used in the Kapoor laboratory to 
ectopically recruit the PP2A regulatory subunit R5B to the chromosome “arm”, by using 
an H2B-FRB, FKBP-R5B system (Dr Lei Tan, Kapoor laboratory, personal communication).  
Encouraged by this background, I decided to use the rapamycin- dependent FRB-
FKBP dimerization to conditionally localize Mad1 at the kinetochore by inducing its 
dimerization with Mis12. To prevent the default localization of Mad1 to kinetochores, I 
decided to use a truncation of Mad1 (Mad1F10) that lacks amino acids 1-320, which 
encode Mad1’s kinetochore-localizing sequences (Canman et al., 2002). I produced a 
FKBP-Mad1F10-GFP construct (Fig. A.1) and used it together with the previously 







Figure A.1 Schematic representation of FRB-FKBP dimerization-mediated system for 
microtubule-independent, conditional checkpoint arrest. (a) FRB and FKBP dimerize in 
the presence of rapamycin and separate upon rapamycin removal. (b) Proposed system: 
in cells expressing Mis12-FRB and FKBP-Mad1F10, the addition of rapamycin would 
recruit Mad1F10 to kinetochores through the dimerization of FRB and FKBP, which 
would lead to checkpoint arrest. Upon rapamycin removal, dimerization would be 
abrogated, Mad1F10 would be released from kinetochores and the spindle assembly 
checkpoint would be overridden (if Mad1-Mad2 removal from bioriented kinetochores 




I generated and examined stable cell lines or transient transfections in all possible 
permutations of the components: I made a double stable cell line with both constructs, 
stable cell lines with a single component to which I transiently transfected the other 
one, or transiently transfected both elements under a variety of protocols. To examine 
the dimerization dynamics of FKBP-Mad1F10 and FRB-Mis12, I performed near 
simultaneous live-imaging for mCherry and GFP channels of metaphase-arrested cells 
after the addition of 20 nM rapamycin. Under none of the conditions examined did I see 
GFP signal at (Mad1F10 recruitment to) the kinetochores, even after incubation in 50 
nM of rapamycin for over 6 hours (for comparison, PP2A R5B was 8-fold enriched after 
15 min in 20 nM rapamycin, Dr Tan, personal communication). It is likely this is due to 
either low expression levels of Mis12-FRB or low level of recruitment at the 
kinetochores (also observed by Dr Tan). Moreover, GFP signal in the cytoplasm was 
heterogeneous and mostly localized to cytoplasmic aggregations. In addition to these 
setbacks, the fact that it would be difficult to wash rapamycin off to reverse the 
dimerization prompted me to stop optimizing this system and focus on an alternative 
strategy instead. 
Shield1-dependent FKBP(L106P)-Mis12-Mad1 fusion protein level control 
My second approach towards the development of a system for conditional checkpoint 
arrest and release independent of the checkpoint’s primary signal was the FKBP*/Shield 
system developed by Dr Wandless and colleagues (Banaszynski et al., 2006). They 
developed a system for the control of protein levels by manipulating the degradation of 
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a novel degron consisting of a FKBP mutant (L106P) with the rapamycin-derived small 
molecule “Shield”. FKBP* remains semi-unfolded in the cytoplasm and is thus targeted 
for degradation by the proteosome. If fused to a protein of interest, FKBP* will act as a 
degradation tag for the fusion protein. In the presence of Shield, FKBP* can fold 
properly and it thus “shielded” from its degradation. Dr Wandless’ group showed that 
this system allows specific, rapid, reversible, tunable control of protein levels in 
interphase cells (Fig. A.2a). The strategy has been successfully used with a variety of 
proteins in cells and whole organisms (e.g. Banaszynski et al., 2008, Herm-Gotz et al., 
2007, Armstrong and Goldberg, 2007). 
 The system seemed applicable to regulate Mad1 at kinetochores by 
manipulating protein levels of Mis12-Mad1 as opposed to manipulating Mad1 
recruitment. Because all characterization of the FKBP*/Shield system had been done in 
interphase cells, I first needed to validate the approach in single mitotic cells. In the 
following sections, I describe my validation of the system in mitotic cells using FKBP*-






Figure A.2 Schematic representation of FKBP*/Shield-mediated system for 
microtubule-independent, conditional checkpoint arrest. (a) FKBP* is a degron that 
targets fused proteins of interest (POI) for degradation. The small molecule Shield 
allows the correct folding of FKBP* and prevents its degradation, thus rescuing 
expression levels of the POI.  (b) Proposed system: in cells expressing FKBP*-Mis12-
Mad1, the addition of Shield would rescue the expression of the fusion protein, which 
would be recruited to kinetochores and, analogously to mCherry-Mis12-Mad1, lead to 
checkpoint arrest. Upon Shield removal, FKBP*-Mis12-Mad1 would be degraded and the 
spindle assembly checkpoint would be overridden (if Mad1-Mad2 removal from 
bioriented kinetochores were sufficient for checkpoint silencing).  
114 
 
Validation with FKBP*-GFP 
To examine whether the FKBP*/Shield system can be used in mitotic cells and, if so, 
whether it exhibits the same kinetics as in interphase cells, I fused FKBP* to GFP and 
made stable FKBP*-GFP RPE-1 and HeLa cell lines. I arrested the cells in mitosis using the 
microtubule depolymerizing drug nocodazole and followed the changes in GFP protein 
levels by quantifying the fluorescence signals of the cells upon Shield wash-in (to 
measure GFP “rescue”) or Shield wash-out (to measure GFP degradation). 
Shield-dependent rescue and FKBP* degradation were observable at a single-cell 
level in interphase and mitotic (nocodazole-arrested) cells. The kinetics of GFP rescue in 
mitotic cells in the presence of 1 μM Shield reached a ~2-fold enrichment (relative to 
starting levels) by 5 h (Fig. A.3 b, e). Published experiments show that FKBP* is rescued 
to ~10% of its maximal level by 4 h interphase cells (Banaszynski et al., 2006). Because I 
imaged cells for five to eight hours, I was not able to record the maximum rescue levels. 
Nevertheless, taking the published data as reference, I would expect a ~20-fold 
enrichment of FKBP* fusion protein levels by 24 h in the presence of Shield. Higher final 
concentrations of Shield should also improve the extent of protein level rescue, but this 
variable was not explored. The kinetics of FKBP*-mediated degradation of GFP were 
similar to the rates seen for interphase NIH-3T3 cells for both interphase and mitotic 
cells (Banaszynski et al., 2006): after 16 h-22 h exposure to 1 μM Shield, half-maximal 








Figure A.3 Shield-dependent regulation of GFP expression levels in RPE-1 cells. (a-f) A 
stable retroviral RPE-1 cell line containing FKBP*-GFP was subjected to addition of 1 μM 
Shield (a, b, e) or its removal after overnight incubation (c,d,f). Interphase (a, c) and 
mitotic (b, d) cells were identified imaged in approximately hourly intervals (shown in 
top right corner of each image). (e,f) GFP fluorescence levels were quantified for each 




From these preliminary experiments I conclude that the FKBP*/Shield system 
can be used to control protein levels in mitotic cells and that the changes in GFP levels in 
mitosis are similar to those seen in interphase cells. In the next section, I describe how I 
have started using this system to conditionally arrest and release cells in and out of 
mitosis, independently of the checkpoint’s primary signal. 
Experimentation with FKBP*-Mis12-Mad1 
To regulate the levels of Mad1 present at the kinetochores, I decided to make the fusion 
protein mCherry-FKBP*-Mis12-Mad1. Preliminary experiments using transient 
transfection showed that the fusion is rescued by Shield (1 μM), that the stabilized 
fusion protein localizes at kinetochores and that it induces metaphase arrest in 
agreement with data described in Chapter 2 for mCh-Mis12-Mad1 (Fig. A.4 and 2.3). In 
fact, the mitotic index increase seen with a 24-hour rescue of mCherry-FKBP*-Mis12-
Mad1 (46%, 1 μM Shield, > 250 cells, 2 coverslips, 1 experiment) was higher than that 
previously seen with 24-hour expression of mCherry-Mis12-Mad1 (27.6% ± 2%, n= 3 
independent experiments, > 400 cells counted per condition per time; Fig. A.4 and 2.3). 
Although these percentages may not be directly comparable, the strong metaphase 
arrest seen with Shield rescue was certainly encouraging.  
The mCherry-FKBP*-Mis12-Mad1 fusion protein was detectable by 
immunofluorescence but not by live imaging (presumably because expression level was 
below fluorescence detection limit, as seen with other Mis12 constructs, Dr Tan, 
personal communication). Hence, I decided to make a stable cell line, such that I could 
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incubate the cells in medium with Shield for longer times. A HeLa mCherry-FKBP*-




Figure A.4 Shield-dependent expression and kinetochore localization of mCherry-
FKBP*-Mis12-Mad1 in HeLa cells. (a, b) Twenty-four hours after transient transfection 
with mCherry-FKBP*-Mis12-Mad1, HeLa cells were incubated in 1 µM Shield (b) or an 
equivalent amount of ethanol (a). Twenty-four hours later, they were imaged live. No 
mCherry signal was detectable for either population (not shown). Following these live 
imaging experiments (i.e. after a ~ 28-hour incubation in Shield or ethanol), additional 
equivalent coverslips were fixed and processed for immunofluorescence.  Staining for 
mCherry is shown, together with DIC image of these fixed cells. Scale bar, 10 µm.  
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Lac-Tet repressor/operator system 
The third approach to study checkpoint signaling independently of its primary signal that 
I will describe is a system for conditionally recruiting Mad1 and other checkpoint 
components to ectopic chromosomal locations, i.e. at a specific point on the 
chromosome, away from the kinetochore. This system would allow us to investigate 
long-standing questions on checkpoint signaling. For instance, can we reconstitute 
checkpoint activity away from the kinetochore? If so, what are the minimal 
requirements for checkpoint signaling? The system would also allow us to examine 
checkpoint signal amplification and re-evaluate the long-standing belief that a single 
non-bioriented chromosome is sufficient for checkpoint arrest in a more precise and 
controlled manner. 
 The system that we envisioned for achieving this is a dual lac 
operator/repressor- tet element/repressor system, based on reagents previously 
developed by Dr Misteli (NIH; Soutoglou et al., 2007). These and similar systems have 
been successfully used to recruit DNA damage proteins to an experimentally controlled 
DNA double strand break, as well as for visualizing gene expression in real time and 
following chromosome segregation patterns (Chubb et al., 2002, Janicki et al., 2004, 
Bakhoum et al., 2009, Thompson and Compton, 2010). Dr Misteli’s system consists of a 
NIH-3T3-derived cell line that contains a stable insertion of an array of lac operators 
(lacO), followed by a ISceI restriction site, followed by an array of tetracycline responsive 




We hypothesized that, if we made a derivation of the lac–ISceI–tet cell line that also 
stably expressed fusion proteins of the lac-repressor (lacI) and tet-repressor (TetR) with 
checkpoint proteins, we would be able to conditionally recruit checkpoint proteins to 
the ectopic location to examine the questions on checkpoint signaling outlined above 
(Fig. A.5).  
 
 
Figure A.5 Schematic representation of lac and tet operator/repressor recruitment-
mediated system for microtubule-independent, conditional checkpoint arrest from an 
ectopic location. (a) The cells used in the proposed system contain a stable, non-
centromeric, chromosomal insertion of an array of lac operators followed by an array of 
tet responsive elements. The cells would also express fusion proteins of combinations of 
checkpoint proteins (Mad1 and Mps1 depicted) fused to the lac and tet repressors, 
respectively. (b) Upon the removal of IPTG and addition of doxycycline, the repressor-
fused checkpoint proteins would be recruited to the corresponding array, which may 
lead to checkpoint arrest.  
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We reasoned that we might be able to reconstitute checkpoint activity by combining 
the ectopic recruitment of two different classes of checkpoint proteins: a structural, 
detection protein (e.g. Mad1) and an amplification protein (e.g. a checkpoint kinase). 
We decided to start with a combination of a TetR-Mad1 and Mps1-lacI. Experiments to 




Materials and methods 
Cell lines, and plasmid and siRNA transfection 
HeLa and NIH-3T3 cells were grown in Dulbecco's modified Eagle's medium (DMEM; 
Invitrogen) and RPE-1 cells, in DMEM-F12 1:1 mixture (Invitrogen), supplemented with 
10% fetal bovine serum (HeLa and RPE-1; Sigma) or 10% bovine calf serum (NIH-3T3; 
Sigma), 2 mM L-Glutamine (Invitrogen), 1X non-essential amino acid solution 
(Invitrogen) and penicillin–streptomycin (100 U ml-1 and 100 μg ml-1 respectively; 
Invitrogen), at 37 °C in a humidified atmosphere with 5% CO2. Cells were plated on poly-
D-Lysine-coated (Sigma) glass coverslips (Fisher Scientific) in 6-well or 12-well dishes.  All 
stable cell lines were generated by retroviral infection with pMSCV-based plasmids with 
the appropriate open reading frame (ORF) fused to the relevant fusion partner by 
overlap PCR and cloned into GFP- or mCherry-tagged vectors by Gateway technology, 
followed by selection with puromycin (Sigma), following suppliers’ and standard 
protocols. The linker used between the Mis12, H2B or CENP-B(1-158) and Mad1 (or AA) 
ORFs was: 5’- GGCGGTTCACGCGGCCGCTCAAGCTTGGGAGGCGGTAGT-3'.  
 All plasmid transfections were done with FuGENE HD (Roche Diagnostics), 
following manufacturer’s instructions, 24 hours (unless otherwise specified) before 
processing for immunofluorescence, live imaging or lysis for western blots. siRNA 
transfections were performed by reverse transfection with Lipofectamine RNAiMax 
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(Invitrogen) following manufacturer’s instructions,  24 hours before plasmid 
transfection. siRNA duplexes against Mad2 (5'-AAGAGUCGGGACCACAGUUUA-3'), BubR1 
(5'-AACGGGCATTTGAATATGAAA-3') and GFP (5'-GGCAAGCUGACCCUGAAGUUC-3') were 
purchased from Dharmacon Research.  
Antibodies 
Antibodies used for immunofluorescence were: polyclonal antibodies against mCherry 
(1: 500; custom-generated and validated by L. Tan, Kapoor laboratory, by immunization 
of rabbits with recombinant GST-tagged full-length mCherry at Cocalico Biologicals and 
subsequent serum affinity purification using a HiTrap NHS activated column, GE 
Healthcare Life Sciences; antibody directly conjugated to Dy-light 549 from Thermo 
Scientific was used for CENP-E co-localization experiments), CENP-E (HX-1; 1: 2000; a gift 
from T. Yen, Fox Chase Cancer Center, Philadelphia, PA), ZW10 (1: 1000; abcam), anti-
gamma-tubulin (1:500 dilution, Sigma-Aldrich, T6557); monoclonal antibodies against  -
tubulin (DM1A, FITC-conjugated; 1: 6000 Sigma-Aldrich, F2168), Mad1 (9B10; 1: 500; 
Santa Cruz Biotechnology), p150Glued (1: 1000; BD Transduction Laboratories), Bub1 (1: 
1000; abcam) and ROD (43-K; 1: 100; Santa Cruz); human CREST anti-serum (1: 20000; a 
gift from W. Brinkley, Baylor College of Medicine, Houston, TX). Secondary antibodies 
conjugated to fluoroscein isothyocyante (FITC), Dylight-549, DyLight 649- or Cy5 were 
from Jackson ImmunoResearch (1:400). The same mCherry (1: 1000) and anti-Mad1 (1: 
500) antibodies were used for western blots, following standard procedures. Secondary 
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antibodies were IRDye 800CW from Li-Cor Biosciences. Blots were detected using the 
Odyssey Infrared Imaging System (Li-Cor). 
Immunofluorescence microscopy 
For all immunofluorescence experiments, cells were pre-extracted with 100 mM K-Pipes 
at pH 6.9, 4 M Glycerol, 1 mM EGTA, 5 mM MgCl2 and 0.5% Triton X-100 at 37 °C for 90 
s and then fixed with 3.7% formaldehyde in 100 mM PIPES at pH 6.9, 10 mM EGTA, 1 
mM MgCl2and 0.2% Triton X-100 at room temperature (or on ice, for cold-treatment 
experiments) for 10 min. Cells were blocked with 2% bovine serum albumin and 0.1% 
Triton-X in TBS for 15 min. Antibodies were diluted in the same medium. DNA was 
stained with Hoechst 33342 (Sigma). 
Images were acquired as Z-stacks with 0.2 μm spacing using a 100×, 1.35 NA 
objective on a DeltaVision Image Restoration Microscope (Applied Precision Instruments 
and Olympus) and processed by iterative constrained deconvolution (SoftWoRx, Applied 
Precision Instruments). Images shown are maximal intensity projections of the Z-stacks 
that were cropped and processed using ImageJ (NIH). Magnified optical sections (insets) 
show individual kinetochores more clearly. Image analysis was performed using 
SoftWoRx or ImageJ (NIH) software. 
For chromosome spreads, cells were arrested in nocodazole (1 μg ml-1) for 60 min, 
harvested by trypsinization, incubated in 0.0075 M KCl for 30 min and spun in a cytospin 
at 1000 r.p.m. for 1 min before processing for immunofluorescence as above. 
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Small-molecule inhibition treatments 
For microtubule depolymerization, cells were incubated in 1 μg ml-1 nocodazole at 37 °C 
for 45 min before fixation. For cold treatment, cells were incubated with 10 μM MG132 
for 2 h and then incubated in ice-cold L-15 medium (Invitrogen) on ice for 10 min before 
fixation. For inhibition of Aurora B activity, before fixation, cells were incubated in 50 
nM hesperadin for 90 min, 2 μM ZM447439 for 60 min, or equivalent amounts of DMSO 
for the respective intervals, at 37 °C. For inhibition of Mps1 activity, cells were incubated 
in 10 μM Mps1-IN-1 (a kind gift from N. Gray, Harvard Medical School, Boston, MA) or 
500 nM reversine (Cayman Chemicals) for 2 hours. For Plk-1 inhibition, cells were 
incubated in 80 nM BI2536 for 90 min before fixation. For all instances were cells were 
counted, DNA (stained with Hoechst stain) and spindle morphology were used to 
determine cell cycle stage.  
For analysis of the effects on ciliobrevin compounds on the spindle, cells were 
incubated in medium containing 10 µM MG132 for 90 min.  The medium was then 
exchanged with DMEM containing 0.5% (v/v) calf serum, 10 µM MG132, and either 50 
µM of the indicated benzoyl dihydroquinazolinones or an equivalent amount of the 
DMSO vehicle, and the cells were cultured for an additional 60 min at 37 °C.  For cold-
treatment experiments, the cells were incubated on ice, and the medium was 
exchanged with ice-cold DMEM containing 0.5% (v/v) calf serum, 10 µM MG132, and 
either 50 µM of the indicated compounds or an equivalent amount of the DMSO 
vehicle.   
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To examine the localization of p150Glued, ZW10, and CENP-E, NIH-3T3 cells were 
incubated for 45 min with DMEM containing 0.5% fetal bovine serum and either 50 µM 
ciliobrevin D, 50 µM analog 2, or an equivalent amount of DMSO.  The cells were then 
incubated in medium that also contained 1 µg/mL nocodazole (and the respective 
compounds/DMSO) for another 45 min.  The cells were fixed as above. 
p150Glued localization in cells with intact microtubules was also examined by 
culturing NIH-3T3 cells in DMEM containing 10% fetal bovine serum and 10 µM MG132 
for 90 min. The medium was then exchanged with DMEM containing 0.5% (v/v) fetal 
bovine serum, 10 µM MG132, and 50 µM ciliobrevin D or an equivalent amount of 
DMSO.  The cells were then fixed and processed for immunostaining as above. The anti-
p150Glued and CREST antibodies were incubated overnight at 4 °C; all other antibodies 
were incubated for 1 hour at room temperature. 
Live imaging 
Cells were grown on 22 mm × 22 mm glass coverslips (Fisher Scientific) coated with poly-
D-lysine (Sigma) and imaged one day or two days after transfection (with mCherry-
Mis12-Mad1 or mCh-H2B-Mad1, respectively), by mounting in Rose chambers and using 
L-15 medium without phenol-red (Invitrogen), at 35–37 °C. Images were acquired using 
a Nikon TE2000 confocal microscope equipped using a Plan Apochromat 100X/1.4 NA 
oil-immersion objective and a PerkinElmer Wallac UltraView confocal head, an argon ion 
laser (Solamere) and Metamorph software (Universal Imaging). GFP and mCherry 
fluorescences were obtained with 488-nm and 568-nm excitation filters, respectively. 
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Confocal stacks were acquired with 0.5 μm spacing. Images were analyzed and 
processed with either Metamorph or ImageJ software. Images shown are maximal 
projections of the Z-stacks. 
For Aurora B inhibition experiments, hesperadin or DMSO were washed into the 
chamber by exchanging the L-15 medium (10% fetal bovine serum) with the compounds 
at the aforementioned concentrations. For live-imaging studies of ciliobrevin effects 
wash-in experiments of mitotic cells were conducted by adding L-15 medium containing 
0.5% fetal bovine serum and either 50 µM ciliobrevin D or an equivalent amount of 
DMSO.  In washout experiments, the compound or solvent vehicle was removed by 
exchanging the medium twice with L-15 containing 10% FBS.  To study the effects of 
ciliobrevins on MG132-arrested cells, the GFP-tubulin-expressing cells were incubated in 
L-15 medium containing 10% fetal bovine serum and 10 µM MG132. Thirty minutes 
later, the medium was exchanged to L-15 with 0.5% fetal bovine serum, 10 µM MG132, 
and either 30 uM of the indicated compounds or an equivalent amount of DMSO.  Fifty 
minutes after the wash-in, the compounds were washed out by exchanging the medium 
twice with L-15 containing 10% fetal bovine serum and 10 µM MG132.   
Fluorescence-signal quantification 
To quantify interphase microtubule intensities, the GFP-tubulin-expressing NIH-3T3 cells 
were incubated with L-15 medium containing 0.5% fetal bovine serum and either 30 µM 
ciliobrevin D or an equivalent amount of DMSO for 15 min.  Interphase cells were 
identified by DIC microscopy, and an 8- to 12-plane Z-stack (0.2 µm step size) 
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encompassing the network of cytoplasmic microtubules was acquired for the GFP 
channel.  For ciliobrevin D experiments, a mitotic cell was imaged before the interphase 
cells, to ensure microtubule depolymerization had occurred.  Ciliobrevin D or DMSO was 
washed out by exchanging the medium twice with L-15 containing 10% fetal bovine 
serum 35-50 min after the initial addition of compound or solvent vehicle.  The cells 
were then re-visited and imaged as before, approximately 15 min after the wash-out (at 
which time the microtubule density of the imaged mitotic cells had recovered).  To 
quantify microtubule intensity in individual cells before and after ciliobrevin/DMSO 
wash-out, planes of the Z-stack that showed maximal microtubule intensity were 
summed, and GFP intensity was measured for a region of interest in the cell cytoplasmic 
and in a nearby background area of the same size.  The background-corrected intensity 
was calculated as (GFP-tubulin fluorescence – background fluorescence)/background 
fluorescence, and the corresponding ratio of post- and pre-wash-out intensities was 
calculated for each cell. 
To quantify intensity of mCherry, p150Glued, ZW10 or CENP-E signal at individual 
kinetochores, CREST signal from deconvolved Z-stacks was used to identify individual 
kinetochores. A region of interest (ROI) was drawn at the corresponding position for the 
mCherry channel, at the identified planes, and the integrated density of the sum of the 
ROIs was calculated. To account for background fluorescence, the corrected 
fluorescence was calculated as in ref.15: briefly, by measuring the fluorescence of a 
slightly larger box and scaling the “inner” fluorescence to the ratio of the areas. The 
same treatment was done for the corresponding CREST staining, and the corrected 
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mCherry fluorescence was normalized to the corrected CREST fluorescence. An 
analogous method was used to measure the mCherry or GFP fluorescence of whole cells 
or spindles, after the summation of fluorescence of individual planes of a Z-stack 
acquired by live imaging. 
Appendix methods 
Rapamycin-dependent, FRB-FKBP-mediated Mis12-Mad1 dimerization 
The pMSCV Mis12-mCherry-FRB construct was a gift from Dr Lei Tan (Kapoor 
laboratory). The pMSCV FKBP-Mad1F10-GFP construct was produced by PCR overlap 
cloning, followed by Gateway cloning, using standard or manufacturer’s procedures. 
HeLa stable cell lines of either construct or both constructs together were produced by 
retroviral infection, followed by selection with puromycin (and subsequently 
hygromycin, for the double cell line). For the single cell lines, the remaining construct 
was transiently transfected using Fugene HD (Roche Diagnostics). Subsequent 
treatments were carried out 24 or 48 hours after transfection (both options were 
examined fully in different experiments). To examine dimerization of FKBP-Mad1F10-
GFP and Mis12-mCherry-FRB, cells were arrested in metaphase with 10 µM MG132 for 
30 min and metaphase cells were localized and imaged live with GFP and mCherry 
channels to obtain respective Z-stacks. The medium was then exchanged to one 
containing 10 µM MG132 and 20 nM rapamycin and the cells were re-visited and 
imaged at 30 min intervals for over 5 hours. 
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Shield1-dependent FKBP*-Mis12-Mad1 fusion protein level control 
The pMSCV FKBP*-GFP and mCherry-FKBP*-Mis12-Mad1 constructs were produced by 
PCR overlap cloning, followed by Gateway cloning, using standard or manufacturer’s 
procedures. The original FKBP* plasmid was a gift from Dr Matthew Pratt (USC). HeLa 
and RPE-1 stable cell lines of the GFP construct were produced by retroviral infection, 
followed by selection with puromycin. For mCherry-FKBP*-Mis12-Mad1, HeLa cells were 
transiently transfected using Fugene HD; subsequent treatments were done 24 hours 
after transfection. To examine the kinetics of Shield-dependent rescue of FKBP*-GFP or 
mCherry-FKBP*-Mis12-Mad1, cells were arrested in mitosis by incubation with 1ug/ml 
nocodazole for 30-45 min, and mitotic and interphase cells were localized and imaged 
live with DIC and GFP channels. The medium was then exchanged to one containing 
1ug/ml nocodazole and 1 µM Shield (Clontech; or an equivalent amount of ethanol, as 
control) and the cells were re-visited and imaged at hourly intervals for 5 hours. To 
examine the kinetics of FKBP*-GFP degradation upon Shield removal, cells were 
incubated in 1 µM Shield for 16 or 22 hours, they were then incubated in a medium 
containing 1 µM Shield and 1ug/ml nocodazole for 1 hour, at which point mitotic and 
interphase cells were localized and imaged live with DIC and GFP channels. After this 
initial imaging, the medium was exchanged to one containing only 1 µM Shield and the 
cells were re-visited and imaged at hourly intervals for 7 hours. Fluorescence intensity of 
GFP rescue or degradation was measured by calculating the intensity of GFP in the 





Abrieu, A., Magnaghi-Jaulin, L., Kahana, J.A., Peter, M., Castro, A., Vigneron, S., Lorca, T., 
Cleveland, D.W., and Labbe, J.C. (2001). Mps1 is a kinetochore-associated kinase 
essential for the vertebrate mitotic checkpoint. Cell 106, 83-93. 
Arasaki, K., Tani, K., Yoshimori, T., Stephens, D.J., and Tagaya, M. (2007). 
Nordihydroguaiaretic acid affects multiple dynein-dynactin functions in 
interphase and mitotic cells. Mol Pharmacol 71, 454-460. 
Arkin, M.R., and Wells, J.A. (2004). Small-molecule inhibitors of protein-protein 
interactions: progressing towards the dream. Nat Rev Drug Discov 3, 301-317. 
Armstrong, C.M., and Goldberg, D.E. (2007). An FKBP destabilization domain modulates 
protein levels in Plasmodium falciparum. Nat Methods 4, 1007-1009. 
Bader, J.R., and Vaughan, K.T. (2010). Dynein at the kinetochore: Timing, Interactions 
and Functions. Semin Cell Dev Biol 21, 269-275. 
Bakhoum, S.F., Thompson, S.L., Manning, A.L., and Compton, D.A. (2009). Genome 
stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat 
Cell Biol 11, 27-35. 
Banaszynski, L.A., Chen, L.C., Maynard-Smith, L.A., Ooi, A.G., and Wandless, T.J. (2006). 
A rapid, reversible, and tunable method to regulate protein function in living cells 
using synthetic small molecules. Cell 126, 995-1004. 
Banaszynski, L.A., Liu, C.W., and Wandless, T.J. (2005). Characterization of the 
FKBP.rapamycin.FRB ternary complex. J Am Chem Soc 127, 4715-4721. 
Banaszynski, L.A., Sellmyer, M.A., Contag, C.H., Wandless, T.J., and Thorne, S.H. (2008). 
Chemical control of protein stability and function in living mice. Nat Med 14, 
1123-1127. 
Barford, D. (2012). Structural insights into anaphase-promoting complex function and 
mechanism. Philos Trans R Soc Lond B Biol Sci 366, 3605-3624. 
Barnhart, E.L., Dorer, R.K., Murray, A.W., and Schuyler, S.C. (2011). Reduced Mad2 
expression keeps relaxed kinetochores from arresting budding yeast in mitosis. 
Mol Biol Cell 22, 2448-2457. 
131 
 
Blacque, O.E., Cevik, S., and Kaplan, O.I. (2008). Intraflagellar transport: from molecular 
characterisation to mechanism. Front Biosci 13, 2633-2652. 
Bouchard, P., Penningroth, S.M., Cheung, A., Gagnon, C., and Bardin, C.W. (1981). 
erythro-9-[3-(2-Hydroxynonyl)]adenine is an inhibitor of sperm motility that 
blocks dynein ATPase and protein carboxylmethylase activities. Proc Natl Acad Sci 
U S A 78, 1033-1036. 
Bullock, S.L., Nicol, A., Gross, S.P., and Zicha, D. (2006). Guidance of bidirectional motor 
complexes by mRNA cargoes through control of dynein number and activity. Curr 
Biol 16, 1447-1452. 
Burke, D.J., and Stukenberg, P.T. (2008). Linking kinetochore-microtubule binding to the 
spindle checkpoint. Developmental Cell 14, 474-479. 
Canman, J.C., Sharma, N., Straight, A., Shannon, K.B., Fang, G., and Salmon, E.D. (2002). 
Anaphase onset does not require the microtubule-dependent depletion of 
kinetochore and centromere-binding proteins. J Cell Sci 115, 3787-3795. 
Carter, A.P., Cho, C., Jin, L., and Vale, R.D. (2011). Crystal structure of the dynein motor 
domain. Science 331, 1159-1165. 
Chao, W.C., Kulkarni, K., Zhang, Z., Kong, E.H., and Barford, D. (2012). Structure of the 
mitotic checkpoint complex. Nature 484, 208-213. 
Cheeseman, I.M., and Desai, A. (2008). Molecular architecture of the kinetochore-
microtubule interface. Nat Rev Mol Cell Biol 9, 33-46. 
Cheeseman, I.M., Niessen, S., Anderson, S., Hyndman, F., Yates, J.R., 3rd, Oegema, K., 
and Desai, A. (2004). A conserved protein network controls assembly of the outer 
kinetochore and its ability to sustain tension. Genes Dev 18, 2255-2268. 
Chen, R.H., Waters, J.C., Salmon, E.D., and Murray, A.W. (1996). Association of spindle 
assembly checkpoint component XMAD2 with unattached kinetochores. Science 
274, 242-246. 
Chen, R.H., Shevchenko, A., Mann, M., and Murray, A.W. (1998). Spindle checkpoint 
protein Xmad1 recruits Xmad2 to unattached kinetochores. J Cell Biol 143, 283-
295. 
Chen, R.H., Brady, D.M., Smith, D., Murray, A.W., and Hardwick, K.G. (1999). The spindle 
checkpoint of budding yeast depends on a tight complex between the Mad1 and 
Mad2 proteins. Mol Biol Cell 10, 2607-2618. 
132 
 
Chou, T.F., Brown, S.J., Minond, D., Nordin, B.E., Li, K., Jones, A.C., Chase, P., Porubsky, 
P.R., Stoltz, B.M., Schoenen, F.J., et al. (2011). Reversible inhibitor of p97, DBeQ, 
impairs both ubiquitin-dependent and autophagic protein clearance pathways. 
Proc Natl Acad Sci U S A 108, 4834-4839. 
Chubb, J.R., Boyle, S., Perry, P., and Bickmore, W.A. (2002). Chromatin motion is 
constrained by association with nuclear compartments in human cells. Curr Biol 
12, 439-445. 
Chung, E., and Chen, R.H. (2002). Spindle checkpoint requires Mad1-bound and Mad1-
free Mad2. Mol Biol Cell 13, 1501-1511. 
De Antoni, A., Pearson, C.G., Cimini, D., Canman, J.C., Sala, V., Nezi, L., Mapelli, M., 
Sironi, L., Faretta, M., Salmon, E.D., et al. (2005). The Mad1/Mad2 complex as a 
template for Mad2 activation in the spindle assembly checkpoint. Curr Biol 15, 
214-225. 
DeLuca, J.G., Howell, B.J., Canman, J.C., Hickey, J.M., Fang, G., and Salmon, E.D. (2003). 
Nuf2 and Hec1 are required for retention of the checkpoint proteins Mad1 and 
Mad2 to kinetochores. Curr Biol 13, 2103-2109. 
DeLuca, J.G., and Musacchio, A. (2012). Structural organization of the kinetochore-
microtubule interface. Curr Opin Cell Biol 24, 48-56. 
DeWitt, M.A., Chang, A.Y., Combs, P.A., and Yildiz, A. (2012). Cytoplasmic dynein moves 
through uncoordinated stepping of the AAA+ ring domains. Science 335, 221-225. 
Ditchfield, C., Johnson, V.L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A., 
Keen, N., and Taylor, S.S. (2003). Aurora B couples chromosome alignment with 
anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 161, 
267-280. 
Dujardin, D.L., and Vallee, R.B. (2002). Dynein at the cortex. Curr Opin Cell Biol 14, 44-
49. 
Emanuele, M.J., Lan, W., Jwa, M., Miller, S.A., Chan, C.S., and Stukenberg, P.T. (2008). 
Aurora B kinase and protein phosphatase 1 have opposing roles in modulating 
kinetochore assembly. J Cell Biol 181, 241-254. 
Erzberger, J.P., and Berger, J.M. (2006). Evolutionary relationships and structural 
mechanisms of AAA+ proteins. Annu Rev Biophys Biomol Struct 35, 93-114. 
Fang, G. (2002). Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit 
anaphase-promoting complex. Mol Biol Cell 13, 755-766. 
133 
 
Faulkner, N.E., Dujardin, D.L., Tai, C.Y., Vaughan, K.T., O'Connell, C.B., Wang, Y., and 
Vallee, R.B. (2000). A role for the lissencephaly gene LIS1 in mitosis and 
cytoplasmic dynein function. Nat Cell Biol 2, 784-791. 
Firestone, A.J., Weinger, J.S., Maldonado, M., Barlan, K., Langston, L.D., O'Donnell, M., 
Gelfand, V.I., Kapoor, T.M., and Chen, J.K. (2012). Small-molecule inhibitors of the 
AAA+ ATPase motor cytoplasmic dynein. Nature 484, 125-129. 
Gaetz, J., and Kapoor, T.M. (2004). Dynein/dynactin regulate metaphase spindle length 
by targeting depolymerizing activities to spindle poles. J Cell Biol 166, 465-471. 
Goetz, S.C., and Anderson, K.V. (2010). The primary cilium: a signaling centre during 
vertebrate development. Nat Rev Genet 11, 331-344. 
Gorbsky, G.J., Sammak, P.J., and Borisy, G.G. (1987). Chromosomes move poleward in 
anaphase along stationary microtubules that coordinately disassemble from their 
kinetochore ends. J Cell Biol 104, 9-18. 
Griffis, E.R., Stuurman, N., and Vale, R.D. (2007). Spindly, a novel protein essential for 
silencing the spindle assembly checkpoint, recruits dynein to the kinetochore. J 
Cell Biol 177, 1005-1015. 
Grill, S.W., and Hyman, A.A. (2005). Spindle positioning by cortical pulling forces. Dev 
Cell 8, 461-465. 
Hardwick, K.G., Johnston, R.C., Smith, D.L., and Murray, A.W. (2000). MAD3 encodes a 
novel component of the spindle checkpoint which interacts with Bub3p, Cdc20p, 
and Mad2p. J Cell Biol 148, 871-882. 
Hardwick, K.G., and Murray, A.W. (1995). Mad1p, a phosphoprotein component of the 
spindle assembly checkpoint in budding yeast. J Cell Biol 131, 709-720. 
Hardwick, K.G., Weiss, E., Luca, F.C., Winey, M., and Murray, A.W. (1996). Activation of 
the budding yeast spindle assembly checkpoint without mitotic spindle 
disruption. Science 273, 953-956. 
Hartwell, L.H., and Weinert, T.A. (1989). Checkpoints: controls that ensure the order of 
cell cycle events. Science 246, 629-634. 
Hauf, S., Cole, R.W., LaTerra, S., Zimmer, C., Schnapp, G., Walter, R., Heckel, A., van 
Meel, J., Rieder, C.L., and Peters, J.M. (2003). The small molecule Hesperadin 
reveals a role for Aurora B in correcting kinetochore-microtubule attachment and 
in maintaining the spindle assembly checkpoint. J Cell Biol 161, 281-294. 
134 
 
Hegemann, B., Hutchins, J.R., Hudecz, O., Novatchkova, M., Rameseder, J., Sykora, 
M.M., Liu, S., Mazanek, M., Lenart, P., Heriche, J.K., et al. (2011). Systematic 
phosphorylation analysis of human mitotic protein complexes. Sci Signal 4, rs12. 
Hengeveld, R.C., Hertz, N.T., Vromans, M.J., Zhang, C., Burlingame, A.L., Shokat, K.M., 
and Lens, S.M. (2012). Development of a chemical genetic approach for human 
aurora B kinase identifies novel substrates of the chromosomal passenger 
complex. Mol Cell Proteomics 11, 47-59. 
Herm-Gotz, A., Agop-Nersesian, C., Munter, S., Grimley, J.S., Wandless, T.J., 
Frischknecht, F., and Meissner, M. (2007). Rapid control of protein level in the 
apicomplexan Toxoplasma gondii. Nat Methods 4, 1003-1005. 
Hoffman, D.B., Pearson, C.G., Yen, T.J., Howell, B.J., and Salmon, E.D. (2001). 
Microtubule-dependent changes in assembly of microtubule motor proteins and 
mitotic spindle checkpoint proteins at PtK1 kinetochores. Mol Biol Cell 12, 1995-
2009. 
Holland, A.J., and Cleveland, D.W. (2012). Losing balance: the origin and impact of 
aneuploidy in cancer. EMBO Rep 13, 501-514. 
Holzbaur, E.L., Hammarback, J.A., Paschal, B.M., Kravit, N.G., Pfister, K.K., and Vallee, 
R.B. (1991). Homology of a 150K cytoplasmic dynein-associated polypeptide with 
the Drosophila gene Glued. Nature 351, 579-583. 
Hook, P., and Vallee, R.B. (2006). The dynein family at a glance. J Cell Sci 119, 4369-
4371. 
Howell, B.J., Hoffman, D.B., Fang, G., Murray, A.W., and Salmon, E.D. (2000). 
Visualization of Mad2 dynamics at kinetochores, along spindle fibers, and at 
spindle poles in living cells. J Cell Biol 150, 1233-1250. 
Howell, B.J., McEwen, B.F., Canman, J.C., Hoffman, D.B., Farrar, E.M., Rieder, C.L., and 
Salmon, E.D. (2001). Cytoplasmic dynein/dynactin drives kinetochore protein 
transport to the spindle poles and has a role in mitotic spindle checkpoint 
inactivation. J Cell Biol 155, 1159-1172. 
Howell, B.J., Moree, B., Farrar, E.M., Stewart, S., Fang, G., and Salmon, E.D. (2004). 
Spindle checkpoint protein dynamics at kinetochores in living cells. Curr Biol 14, 
953-964. 
Hoyt, M.A., Totis, L., and Roberts, B.T. (1991). S. cerevisiae genes required for cell cycle 
arrest in response to loss of microtubule function. Cell 66, 507-517. 
135 
 
Huangfu, D., and Anderson, K.V. (2005). Cilia and Hedgehog responsiveness in the 
mouse. Proc Natl Acad Sci U S A 102, 11325-11330. 
Hughes, S.M., Vaughan, K.T., Herskovits, J.S., and Vallee, R.B. (1995). Molecular analysis 
of a cytoplasmic dynein light intermediate chain reveals homology to a family of 
ATPases. J Cell Sci 108 ( Pt 1), 17-24. 
Hunt, S.D., and Stephens, D.J. The role of motor proteins in endosomal sorting. Biochem 
Soc Trans 39, 1179-1184. 
Hunt, T., Nasmyth, K., and Novak, B. The cell cycle. Philos Trans R Soc Lond B Biol Sci 
366, 3494-3497. 
Hyman, J. M., Firestone, A. J., Heine, V. M., Zhao, Y., Ocasio, C. A., Han, K., Sun, M., Rack, 
P. G., Sinha, S., Wu, et. al. (2009). Small-molecule inhibitors reveal multiple 
strategies for Hedgehog pathway blockade. Proc Natl Acad Sci U S A 106, 14132-7.  
Inoue, M., Arasaki, K., Ueda, A., Aoki, T., and Tagaya, M. (2008). N-terminal region of 
ZW10 serves not only as a determinant for localization but also as a link with 
dynein function. Genes Cells 13, 905-914. 
Iouk, T., Kerscher, O., Scott, R.J., Basrai, M.A., and Wozniak, R.W. (2002). The yeast 
nuclear pore complex functionally interacts with components of the spindle 
assembly checkpoint. J Cell Biol 159, 807-819. 
Janicki, S.M., Tsukamoto, T., Salghetti, S.E., Tansey, W.P., Sachidanandam, R., Prasanth, 
K.V., Ried, T., Shav-Tal, Y., Bertrand, E., Singer, R.H., et al. (2004). From silencing 
to gene expression: real-time analysis in single cells. Cell 116, 683-698. 
Janke, C., Ortiz, J., Lechner J., Shevchenko A., Shevchenko A., Magiera A.M., Schramm C.  
and Schiebel E. (2001). The budding yeast proteins Spc24p and Spc25p interact 
with Ndc80p and Nuf2p at the kinetochore and are important for kinetochore 
clustering and checkpoint control. EMBO J 20, 777 – 791.  
Janssen, A., Medema, R.H. (2011). Mitosis as an anti-cancer target. Oncogene 30, 2799-
2809. 
Jelluma, N., Dansen, T.B., Sliedrecht, T., Kwiatkowski, N.P., and Kops, G.J. (2010). 
Release of Mps1 from kinetochores is crucial for timely anaphase onset. J Cell Biol 
191, 281-290. 




Kallio, M.J., McCleland, M.L., Stukenberg, P.T., and Gorbsky, G.J. (2002). Inhibition of 
aurora B kinase blocks chromosome segregation, overrides the spindle 
checkpoint, and perturbs microtubule dynamics in mitosis. Curr Biol 12, 900-905. 
Kang, J., Yang, M., Li, B., Qi, W., Zhang, C., Shokat, K.M., Tomchick, D.R., Machius, M., 
and Yu, H. (2008). Structure and substrate recruitment of the human spindle 
checkpoint kinase Bub1. Mol Cell 32, 394-405. 
Kang, J., and Yu, H. (2009). Kinase signaling in the spindle checkpoint. J Biol Chem 284, 
15359-15363. 
Kardon, J.R., and Vale, R.D. (2009). Regulators of the cytoplasmic dynein motor. Nat Rev 
Mol Cell Biol 10, 854-865. 
Karess, R. (2005). Rod-ZW10-Zwilch: a key player in the spindle checkpoint. Trends Cell 
Biol 15, 386-392. 
Kim, J., Kato, M., and Beachy, P.A. (2009). Gli2 trafficking links Hedgehog-dependent 
activation of Smoothened in the primary cilium to transcriptional activation in the 
nucleus. Proc Natl Acad Sci U S A 106, 21666-21671. 
Kim, S., Zaghloul, N.A., Bubenshchikova, E., Oh, E.C., Rankin, S., Katsanis, N., Obara, T., 
and Tsiokas, L. (2011). Nde1-mediated inhibition of ciliogenesis affects cell cycle 
re-entry. Nat Cell Biol 13, 351-360. 
King, E.M., Rachidi, N., Morrice, N., Hardwick, K.G., and Stark, M.J. (2007). Ipl1p-
dependent phosphorylation of Mad3p is required for the spindle checkpoint 
response to lack of tension at kinetochores. Genes Dev 21, 1163-1168. 
King, S.J., Brown, C.L., Maier, K.C., Quintyne, N.J., and Schroer, T.A. (2003). Analysis of 
the dynein-dynactin interaction in vitro and in vivo. Mol Biol Cell 14, 5089-5097. 
King, S.M. (2012). Integrated control of axonemal dynein AAA(+) motors. J Struct Biol. 
Kiyomitsu, T., and Cheeseman, I.M. (2012). Chromosome- and spindle-pole-derived 
signals generate an intrinsic code for spindle position and orientation. Nat Cell 
Biol 14, 311-317. 
Kline, S.L., Cheeseman, I.M., Hori, T., Fukagawa, T., & Desai, A. (2006). The human Mis 
12 complex is required for kinetochore assembly and proper chromosome 
segregation. J Cell Biol 173, 9-17. 
137 
 
Kon, T., Nishiura, M., Ohkura, R., Toyoshima, Y.Y., and Sutoh, K. (2004). Distinct 
functions of nucleotide-binding/hydrolysis sites in the four AAA modules of 
cytoplasmic dynein. Biochemistry 43, 11266-11274. 
Kon, T., Oyama, T., Shimo-Kon, R., Imamula, K., Shima, T., Sutoh, K., and Kurisu, G. 
(2012). The 2.8 A crystal structure of the dynein motor domain. Nature 484, 345-
350. 
Koshland, D.E., Mitchison, T.J., and Kirschner, M.W. (1988). Polewards chromosome 
movement driven by microtubule depolymerization in vitro. Nature 331, 499-504. 
Kulukian, A., Han, J.S., and Cleveland, D.W. (2009). Unattached kinetochores catalyze 
production of an anaphase inhibitor that requires a Mad2 template to prime 
Cdc20 for BubR1 binding. Dev Cell 16, 105-117. 
Kwiatkowski, N., Jelluma, N., Filippakopoulos, P., Soundararajan, M., Manak, M.S., 
Kwon, M., Choi, H.G., Sim, T., Deveraux, Q.L., Rottmann, S., et al. (2010). Small-
molecule kinase inhibitors provide insight into Mps1 cell cycle function. Nat Chem 
Biol 6, 359-368. 
Lad, L., Lichtsteiner, S., Hartman, J.J., Wood, K.W., and Sakowicz, R. (2009). Kinetic 
analysis of Mad2-Cdc20 formation: conformational changes in Mad2 are 
catalyzed by a C-Mad2-ligand complex. Biochemistry 48, 9503-9515. 
Lan, W., and Cleveland, D.W. (2010). A chemical tool box defines mitotic and interphase 
roles for Mps1 kinase. J Cell Biol 190, 21-24. 
Lau, D.T., and Murray, A.W. (2012). Mad2 and Mad3 cooperate to arrest budding yeast 
in mitosis. Curr Biol 22, 180-190. 
Lee, S.H., Sterling, H., Burlingame, A., and McCormick, F. (2008). Tpr directly binds to 
Mad1 and Mad2 and is important for the Mad1-Mad2-mediated mitotic spindle 
checkpoint. Genes Dev 22, 2926-2931. 
Li, A., Saito, M., Chuang, J.Z., Tseng, Y.Y., Dedesma, C., Tomizawa, K., Kaitsuka, T., and 
Sung, C.H. (2011). Ciliary transition zone activation of phosphorylated Tctex-1 
controls ciliary resorption, S-phase entry and fate of neural progenitors. Nat Cell 
Biol 13, 402-411. 
Li, R., and Murray, A.W. (1991). Feedback control of mitosis in budding yeast. Cell 66, 
519-531. 
Li, Y., and Benezra, R. (1996). Identification of a human mitotic checkpoint gene: 
hsMAD2. Science 274, 246-248. 
138 
 
Liu, D., Vader, G., Vromans, M.J., Lampson, M.A., and Lens, S.M. (2009). Sensing 
chromosome bi-orientation by spatial separation of aurora B kinase from 
kinetochore substrates. Science 323, 1350-1353. 
Liu, D., Vleugel, M., Backer, C.B., Hori, T., Fukagawa, T., Cheeseman, I.M., and Lampson, 
M.A. (2010). Regulated targeting of protein phosphatase 1 to the outer 
kinetochore by KNL1 opposes Aurora B kinase. J Cell Biol 188, 809-820. 
Luo, X., Tang, Z., Xia, G., Wassmann, K., Matsumoto, T., Rizo, J., and Yu, H. (2004). The 
Mad2 spindle checkpoint protein has two distinct natively folded states. Nat 
Struct Mol Biol 11, 338-345. 
Luo, X., and Yu, H. (2008). Protein metamorphosis: the two-state behavior of Mad2. 
Structure 16, 1616-1625. 
Maciejowski, J., George, K.A., Terret, M.E., Zhang, C., Shokat, K.M., and Jallepalli, P.V. 
(2010). Mps1 directs the assembly of Cdc20 inhibitory complexes during 
interphase and mitosis to control M phase timing and spindle checkpoint 
signaling. J Cell Biol 190, 89-100. 
Maldonado, M., and Kapoor, T.M. (2011). Constitutive Mad1 targeting to kinetochores 
uncouples checkpoint signaling from chromosome biorientation. Nat Cell Biol 13, 
475-482. 
Mansfeld, J., Collin, P., Collins, M.O., Choudhary, J.S., and Pines, J. (2011). APC15 drives 
the turnover of MCC-CDC20 to make the spindle assembly checkpoint responsive 
to kinetochore attachment. Nat Cell Biol 13, 1234-1243. 
Mao, Y., Desai, A., and Cleveland, D.W. (2005). Microtubule capture by CENP-E silences 
BubR1-dependent mitotic checkpoint signaling. J Cell Biol 170, 873-880. 
Mapelli, M., Massimiliano, L., Santaguida, S., and Musacchio, A. (2007). The Mad2 
conformational dimer: structure and implications for the spindle assembly 
checkpoint. Cell 131, 730-743. 
Martin-Lluesma, S., Stucke, V.M., and Nigg, E.A. (2002). Role of Hec1 in spindle 
checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 297, 
2267-2270. 
Meadows, J.C., Shepperd, L.A., Vanoosthuyse, V., Lancaster, T.C., Sochaj, A.M., Buttrick, 
G.J., Hardwick, K.G., and Millar, J.B. (2011). Spindle checkpoint silencing requires 
association of PP1 to both Spc7 and kinesin-8 motors. Dev Cell 20, 739-750. 
139 
 
Meraldi, P., Draviam, V.M., and Sorger, P.K. (2004a). Timing and checkpoints in the 
regulation of mitotic progression. Dev Cell 7, 45-60. 
Meraldi, P., Honda, R., and Nigg, E.A. (2004b). Aurora kinases link chromosome 
segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 14, 29-
36. 
Merdes, A., Heald, R., Samejima, K., Earnshaw, W.C., and Cleveland, D.W. (2000). 
Formation of spindle poles by dynein/dynactin-dependent transport of NuMA. J 
Cell Biol 149, 851-862. 
Merdes, A., Ramyar, K., Vechio, J.D., and Cleveland, D.W. (1996). A complex of NuMA 
and cytoplasmic dynein is essential for mitotic spindle assembly. Cell 87, 447-458. 
Mitchison, T., Evans, L., Schulze, E., and Kirschner, M. (1986). Sites of microtubule 
assembly and disassembly in the mitotic spindle. Cell 45, 515-527. 
Moore, J.K., Stuchell-Brereton, M.D., and Cooper, J.A. (2009). Function of dynein in 
budding yeast: mitotic spindle positioning in a polarized cell. Cell Motil 
Cytoskeleton 66, 546-555. 
Morgan, D.O. (2008a). SnapShot: cell-cycle regulators I. Cell 135, 764-764 e761. 
Morgan, D.O. (2008b). SnapShot: Cell-cycle regulators II. Cell 135, 974-974 e971. 
Murray, A.W. (2011). A brief history of error. Nat Cell Biol 13, 1178-1182. 
Musacchio, A. (2011). Spindle assembly checkpoint: the third decade. Philos Trans R Soc 
Lond B Biol Sci 366, 3595-3604. 
Musacchio, A., and Salmon, E.D. (2007). The spindle-assembly checkpoint in space and 
time. Nat Rev Mol Cell Biol 8, 379-393. 
Nilsson, J., Yekezare, M., Minshull, J., and Pines, J. (2008). The APC/C maintains the 
spindle assembly checkpoint by targeting Cdc20 for destruction. Nat Cell Biol 10, 
1411-1420. 
Ogura, T., and Wilkinson, A.J. (2001). AAA+ superfamily ATPases: common structure--
diverse function. Genes Cells 6, 575-597. 
Oppermann, F.S., Grundner-Culemann, K., Kumar, C., Gruss, O.J., Jallepalli, P.V., and 
Daub, H. (2012).  Combination of chemical genetics and phosphoproteomics for 
kinase signaling analysis enables confident identification of cellular downstream 
targets. Mol Cell Proteomics 11, O111 012351.Palframan, W.J., Meehl, J.B., 
140 
 
Jaspersen, S.L., Winey, M., and Murray, A.W. (2006). Anaphase inactivation of the 
spindle checkpoint. Science 313, 680-684. 
Pazour, G.J., Wilkerson, C.G., and Witman, G.B. (1998). A dynein light chain is essential 
for the retrograde particle movement of intraflagellar transport (IFT). J Cell Biol 
141, 979-992. 
Petersen, J., and Hagan, I.M. (2003). S. pombe aurora kinase/survivin is required for 
chromosome condensation and the spindle checkpoint attachment response. 
Curr Biol 13, 590-597. 
Petronczki, M., Lenart, P., and Peters, J.M. (2008). Polo on the Rise-from Mitotic Entry to 
Cytokinesis with Plk1. Dev Cell 14, 646-659. 
Pfau, S.J., and Amon, A. (2012). Chromosomal instability and aneuploidy in cancer: from 
yeast to man. EMBO Rep 13, 515-527. 
Pinsky, B.A., and Biggins, S. (2005). The spindle checkpoint: tension versus attachment. 
Trends Cell Biol 15, 486-493. 
Pinsky, B.A., Kung, C., Shokat, K.M., and Biggins, S. (2006). The Ipl1-Aurora protein 
kinase activates the spindle checkpoint by creating unattached kinetochores. Nat 
Cell Biol 8, 78-83. 
Pinsky, B.A., Nelson, C.R., and Biggins, S. (2009). Protein phosphatase 1 regulates exit 
from the spindle checkpoint in budding yeast. Curr Biol 19, 1182-1187. 
Qiu, W., Derr, N.D., Goodman, B.S., Villa, E., Wu, D., Shih, W., and Reck-Peterson, S.L. 
(2012). Dynein achieves processive motion using both stochastic and coordinated 
stepping. Nat Struct Mol Biol 19, 193-200. 
Reddy, S.K., Rape, M., Margansky, W.A., and Kirschner, M.W. (2007). Ubiquitination by 
the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 
446, 921-925. 
Rieder, C.L., Cole, R.W., Khodjakov, A., and Sluder, G. (1995). The checkpoint delaying 
anaphase in response to chromosome monoorientation is mediated by an 
inhibitory signal produced by unattached kinetochores. J Cell Biol 130, 941-948. 
Rieder, C.L., Schultz, A., Cole, R., and Sluder, G. (1994). Anaphase onset in vertebrate 
somatic cells is controlled by a checkpoint that monitors sister kinetochore 
attachment to the spindle. J Cell Biol 127, 1301-1310. 
141 
 
Rosenberg, J.S., Cross, F.R., and Funabiki, H. (2011). KNL1/Spc105 recruits PP1 to silence 
the spindle assembly checkpoint. Curr Biol 21, 942-947. 
Santaguida, S., and Musacchio, A. (2009). The life and miracles of kinetochores. EMBO J 
28, 2511-2531. 
Santaguida, S., Tighe, A., D'Alise, A.M., Taylor, S.S., and Musacchio, A. (2010). Dissecting 
the role of MPS1 in chromosome biorientation and the spindle checkpoint 
through the small molecule inhibitor reversine. J Cell Biol 190, 73-87. 
Santaguida, S., Vernieri, C., Villa, F., Ciliberto, A., and Musacchio, A. (2011). Evidence 
that Aurora B is implicated in spindle checkpoint signaling independently of error 
correction. EMBO J 30, 1508-1519. 
Saurin, A.T., van der Waal, M.S., Medema, R.H., Lens, S.M., and Kops, G.J. (2011). Aurora 
B potentiates Mps1 activation to ensure rapid checkpoint establishment at the 
onset of mitosis. Nat Commun 2, 316. 
Schmidt, H., Gleave, E.S., and Carter, A.P. (2012). Insights into dynein motor domain 
function from a 3.3-A crystal structure. Nat Struct Mol Biol 19, 492-497. 
Schroer, T.A. (2004). Dynactin. Annu Rev Cell Dev Biol 20, 759-779. 
Shah, J.V., Botvinick, E., Bonday, Z., Furnari, F., Berns, M., and Cleveland, D.W. (2004). 
Dynamics of centromere and kinetochore proteins; implications for checkpoint 
signaling and silencing. Curr Biol 14, 942-952. 
Shepperd, L.A., Meadows, J.C., Sochaj, A.M., Lancaster, T.C., Zou, J., Buttrick, G.J., 
Rappsilber, J., Hardwick, K.G., and Millar, J.B. (2012). Phosphodependent 
Recruitment of Bub1 and Bub3 to Spc7/KNL1 by Mph1 Kinase Maintains the 
Spindle Checkpoint. Curr Biol 22, 891-899. 
Simonetta, M., Manzoni, R., Mosca, R., Mapelli, M., Massimiliano, L., Vink, M., Novak, B., 
Musacchio, A., and Ciliberto, A. (2009). The influence of catalysis on mad2 
activation dynamics. PLoS Biol 7, e10. 
Sironi L., Melixetian M., Faretta M., Prosperini E., Helin K., Musacchio A. (2001). Mad2 
binding to Mad1 and Cdc20, rather than oligomerization, is required for spindle 
checkpoint. Embo J 20, 6371-6382. 
Sironi, L., Mapelli, M., Knapp, S., De Antoni, A., Jeang, K.T., and Musacchio, A. (2002). 
Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 




Soutoglou, E., Dorn, J.F., Sengupta, K., Jasin, M., Nussenzweig, A., Ried, T., Danuser, G., 
and Misteli, T. (2007). Positional stability of single double-strand breaks in 
mammalian cells. Nat Cell Biol 9, 675-682. 
Starr, D.A., Williams, B.C., Hays, T.S., and Goldberg, M.L. (1998). ZW10 helps recruit 
dynactin and dynein to the kinetochore. J Cell Biol 142, 763-774. 
Stehman, S.A., Chen, Y., McKenney, R.J., and Vallee, R.B. (2007). NudE and NudEL are 
required for mitotic progression and are involved in dynein recruitment to 
kinetochores. J Cell Biol 178, 583-594. 
Sudakin, V., Chan, G.K., and Yen, T.J. (2001). Checkpoint inhibition of the APC/C in HeLa 
cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154, 
925-936. 
Tang, Z., Bharadwaj, R., Li, B., and Yu, H. (2001). Mad2-Independent inhibition of 
APCCdc20 by the mitotic checkpoint protein BubR1. Dev Cell 1, 227-237. 
Tang, Z., Shu, H., Oncel, D., Chen, S., and Yu, H. (2004). Phosphorylation of Cdc20 by 
Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle 
checkpoint. Mol Cell 16, 387-397. 
Thompson, S.L., and Compton, D.A. (2010). Proliferation of aneuploid human cells is 
limited by a p53-dependent mechanism. J Cell Biol 188, 369-381. 
Vaisberg, E.A., Koonce, M.P., and McIntosh, J.R. (1993). Cytoplasmic dynein plays a role 
in mammalian mitotic spindle formation. J Cell Biol 123, 849-858. 
Vallee, R.B., McKenney, R.J., and Ori-McKenney, K.M. (2012). Multiple modes of 
cytoplasmic dynein regulation. Nat Cell Biol 14, 224-230. 
Vanoosthuyse, V., and Hardwick, K.G. (2009). A novel protein phosphatase 1-dependent 
spindle checkpoint silencing mechanism. Curr Biol 19, 1176-1181. 
Varetti, G., Guida, C., Santaguida, S., Chiroli, E., and Musacchio, A. (2011). Homeostatic 
control of mitotic arrest. Mol Cell 44, 710-720. 
Varma, D., Monzo, P., Stehman, S.A., and Vallee, R.B. (2008). Direct role of dynein motor 
in stable kinetochore-microtubule attachment, orientation, and alignment. J Cell 
Biol 182, 1045-1054. 
Vink, M., Simonetta, M., Transidico, P., Ferrari, K., Mapelli, M., De Antoni, A., 
Massimiliano, L., Ciliberto, A., Faretta, M., Salmon, E.D., et al. (2006). In vitro FRAP 
143 
 
identifies the minimal requirements for Mad2 kinetochore dynamics. Curr Biol 16, 
755-766. 
Wadsworth, P., Lee, W.L., Murata, T., and Baskin, T.I. (2011). Variations on theme: 
spindle assembly in diverse cells. Protoplasma 248, 439-446. 
Wan, X., O'Quinn, R.P., Pierce, H.L., Joglekar, A.P., Gall, W.E., DeLuca, J.G., Carroll, C.W., 
Liu, S.T., Yen, T.J., McEwen, B.F., et al. (2009). Protein architecture of the human 
kinetochore microtubule attachment site. Cell 137, 672-684. 
Waters, J.C., Chen, R.H., Murray, A.W., and Salmon, E.D. (1998). Localization of Mad2 to 
kinetochores depends on microtubule attachment, not tension. J Cell Biol 141, 
1181-1191. 
Weinert, T.A., Hartwell, L.H. (1988). The RAD9 gene controls the cell cycle response to 
DNA damage in Saccharomyces cerevisiae. Science 241, 317-322. 
Windecker, H., Langegger, M., Heinrich, S., and Hauf, S. (2009). Bub1 and Bub3 promote 
the conversion from monopolar to bipolar chromosome attachment 
independently of shugoshin. EMBO Rep 10, 1022-1028. 
Xia, G., Luo, X., Habu, T., Rizo, J., Matsumoto, T., and Yu, H. (2004). Conformation-
specific binding of p31(comet) antagonizes the function of Mad2 in the spindle 
checkpoint. EMBO J 23, 3133-3143. 
Yang, M., Li, B., Liu, C.J., Tomchick, D.R., Machius, M., Rizo, J., Yu, H., and Luo, X. (2008). 
Insights into mad2 regulation in the spindle checkpoint revealed by the crystal 
structure of the symmetric mad2 dimer. PLoS Biol 6, e50. 
Yang, M., Li, B., Tomchick, D.R., Machius, M., Rizo, J., Yu, H., and Luo, X. (2007). 
p31comet blocks Mad2 activation through structural mimicry. Cell 131, 744-755. 
Yen, T.J., Compton, D.A., Wise, D., Zinkowski, R.P., Brinkley, B.R., Earnshaw, W.C., and 
Cleveland, D.W. (1991). CENP-E, a novel human centromere-associated protein 
required for progression from metaphase to anaphase. EMBO J 10, 1245-1254. 
Young, A., Dictenberg, J.B., Purohit, A., Tuft, R., and Doxsey, S.J. (2000). Cytoplasmic 
dynein-mediated assembly of pericentrin and gamma tubulin onto centrosomes. 
Mol Biol Cell 11, 2047-2056. 
Zich, J., Sochaj, A.M., Syred, H.M., Milne, L., Cook, A.G., Ohkura, H., Rappsilber, J., and 
Hardwick, K.G. (2012). Kinase activity of fission yeast Mph1 is required for Mad2 
and Mad3 to stably bind the anaphase promoting complex. Curr Biol 22, 296-301. 
